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INTRODUCTION 
By Carolyn S. Leach, Ph. D.* 
I 
i 
Man has successful ly  faced and overcome the  challenges of t he  space- 
f l i g h t  environment on short-duration missions. However, a decade a f t e r  
t he  inception of t h e  manned U.S. space program, t h e  medical d i r ec to ra t e  
i s  s t i l l  assessing the  physiological changes t h a t  result from working 
i n  the  environment of space. 
A comprehensive review of t he  endocrinological da ta  avai lable  t o  
date w a s  t he  subject  of t he  NASA Manned Spacecraft Center symposium held 
October 5 t o  7,  1970. 
ous experts i n  t h e i r  f i e l d s  t o  assess the  endocrinological changes ob- 
served i n  the Apollo crewmen. 
exper t i se  t h a t  i s  applicable t o  the ove ra l l  endocrine program developed 
f o r  support of t he  Apollo missions and f o r  t he  extended-duration Skylab 
f l i g h t s .  
The purpose of t h e  symposium w a s  t o  assemble var i -  
The attendees all have a spec ia l ized  
The aims of t h i s  endocrine program are three .  
1. The establishment of an operational laboratory f o r  immediate 
endocrinological assays at the Manned Spacecraft Center 
2. The assemblage of a group of endocrinological experts  qua l i f ied  
t o  advise on procedures and the  in te rpre ta t ion  of da ta  
3. 
of ana ly t i ca l  procedures lou i n  sample volume requirements but high i n  
s p e c i f i c i t y  
The advancement of the  f i e l d  of endocrinology by the appl icat ion 
This symposium marked the  f i r s t  meeting of t he  group chosen t o  help 
conduct the NASA Manned Spacecraft Center endocrine program. Each 
attendee made a presentat ion on h i s  spec ia l ty ,  then ed i ted  the  t r ansc r ip t  
of h i s  presentation, which was tape recorded f o r  purposes of compiling 
t h i s  symposium report .  "he 10 presentat ions r e l a t e  t h e  authors' con- 
t r i bu t ions  i n  support of t he  program e i t h e r  w i t h  respect  t o  s tud ies  o r  
t o  methodological development. 
The reader is advised t h a t  the  information presented i s  t h a t  current 
at t h e  time of t he  symposium and t h a t  no attempt has been made t o  update 
these presentat ions by inclusion of more recent data.  
*Chief, Endocrine Laboratory, NASA Manned Spacecraft Center, Houston, 
Texas 77058. 
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1. RED-CELL-MASS AND PLASMA-VOLUME CHANGES OBSERVED 
I N  ASTRONAUTS ON THREE G E M I N I  AND 
THRFE APOLLO MISSIONS 
By P h i l i p  C. Johnson, M.D.* 
INTRODUCTION 
Nuclear-medicine procedures were performed f o r  t h r e e  Gemini and 
th ree  Apollo missions. 
medicine procedures ever performed f o r  crews who have been i n  a weight- 
l e s s  environment, it i s  not possible t o  compare these  r e s u l t s  with any 
o thers .  The nuclear-medicine s tudies  were assigned t o  these  missions 
as one p a r t  of the medical operational support required t o  guarantee 
t h e  s a f e t y  of t h e  crews. 
than research s tud ie s ,  t h e  number of data points w a s  l imi t ed  t o  t h e  
minimum number that w a s  absolutely necessary t o  guarantee crew sa fe ty .  
The missions s tud ie s  have included both t h e  high-oxygen/zero-nitrogen 
atmosphere of t he  Gemini Program and the  somewhat-lower-oxygen/ 
partial-nitrogen atmosphere of t h e  non-lunar-landing Apollo missions. 
Specimens have been obtained a t  t h e  Manned Spacecraft Center, a t  t h e  
Kennedy Space Center, and aboard the recovery c a r r i e r s .  
data included ground-based controls.  
Because these  s tud ie s  are t h e  only nuclear- 
Because these  were opera t iona l  s tud ie s  rather 
The Apollo 
DISCUSSION 
Plasma-Volume Changes 
Before the Mercury missions, it w a s  an t i c ipa t ed  t h a t  cardiovascular 
deconditioning would occur during t h e  t i m e  t h e  crews were i n  a weight- 
l e s s  environment. Bedrest and water immersion are t h e  only ways t o  
simulate weightlessness without f ly ing  a mission. 
t h e  more prolonged Gemini missions, plasma-volume changes were s tud ied  
I n  preparation f o r  
*Professor of Medicine and Head of Nuclear Medicine Section, Baylor 
College of Medicine; Director of Radioisotope Department, The Methodist 
Hospital ,  Houston, Texas 77025. 
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during bedrest  and water immersion of various durations designed t o  s i m -  
u l a t e  t h e  e f f e c t s  of weightlessness. 
a r e  contained i n  t a b l e  1-1, i n  which it i s  shown t h a t  mean plasma volume 
decreased 563 m i l l i l i t e r s  during 12 hours of water immersion, 318 m i l l i -  
l i t e r s  during bedres t ,  and only 151  m i l l i l i t e r s  during cha i r  rest f o r  
similar periods. This l o s s  of plasma volume re su l t ed  i n  a l o s s  of c i r -  
cu la tory  albumin and an increased output of ur ine .  
The r e s u l t s  of one of t he  s tud ies  
The Manned Spacecraft Center r e s u l t s  were combined with published 
s tudies  of plasma-volume changes produced by bedrest  ( f i g .  1-1). Although 
t h e  s tud ie s  shown were not designed t o  be completely a l i k e ,  t h e  differences 
i n  design among the  inves t iga tors  were r e l a t i v e l y  minor. The f igu re  ind i -  
ca tes  t h a t  a mean 10-percent decrease i n  plasma volume was  experienced by 
the  second day of bedrest .  By t h e  27th day, plasma volume decreased t o  
20 percent of t h e  cont ro l  value. Plasma volume returned t o  normal a f t e r  
a period of bedres t ,  but t h e  recovery took more time than t h e  decrease. 
It must be remembered t h a t  f o r  each of these  s tud ie s  considerable blood 
w a s  drawn from t h e  ind iv idua ls ,  a f ac to r  that may have influenced t h e  
r e s u l t s  obtained. 
These r e s u l t s  are compared i n  t a b l e  1-11 with those obtained a f t e r  
t h e  non-lunar-landing missions. The mean percent change a f t e r  each m i s -  
s ion  i s  compared with t h e  percent change expected if t h e  changes i n  t h e  
missions were t o  be similar t o  t h e  bedrest  da ta  shown i n  f i gu re  1-1. 
Certainly these  data do not suggest t h a t  plasma-volume changes 
g rea t e r  than  those predicted from bedrest  would be expected i n  continued 
space f l i g h t s  up t o  a t  l e a s t  1 4  days. 
a f t e r  t h e  Gemini V I 1  mission may represent a compensatory response t o  
t h e  red-cell-mass decrease found during that mission o r  it may be t h a t  
the e f f e c t  on plasma volume i s  se l f - l imi ted .  
The increase i n  plasma volume 
Red-Cell-Mass Changes 
The red-cell-mass changes during t h e  Gemini and Apollo missions w i l l  
be discussed next. The red-cell  m a s s  i s  a more s t a b l e  volume than i s  t h e  
plasma volume. Red c e l l s  cannot be mobilized as can plasma pro te ins ;  
t he re fo re ,  l o s ses  a r e  replaced slowly. Factors changing both red-ce l l  
production and death r a t e  a f f e c t  t h e  t o t a l  c i r cu la t ing  red-cell  mass; 
these  f ac to r s  include bedres t ,  a l t i t u d e ,  physical  conditioning, d i sease ,  
and drugs. 
Bedrest probably causes a decrease i n  red-cell  mass, but such changes 
during bedrest  a r e  not as wel l  documented as plasma-volume changes be- 
cause only i n  recent bedrest  s tud ies  have red-cell-mass determinations 
been performed. Oberfield e t  al .  (ref. 1-1) noted an 8.6-percent mean 
. 
w 
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increase i n  t h e  red-cell  mass of orthopedic p a t i e n t s  who became ambula- 
t o r y  a f t e r  prolonged immobilization. 
unknown. 
The mechanism f o r  these  changes i s  
Changes i n  red-ce l l  mass following a l t i t u d e  changes are wel l  docu- 
mented; however, t h i s  statement needs t o  be qua l i f i ed  i n  t h a t  what i s  
we l l  known i s  t h e  changes r e s u l t i n g  from decreases i n  oxygen tension. 
Not as we l l  documented a r e  t h e  p o t e n t i a l  changes r e s u l t i n g  from a hyper- 
oxic low-pressure environment. The atmosphere used during t h e  Gemini 
and Apollo missions was 100 percent oxygen at 258 t o r r .  This atmosphere 
produces a t o t a l  pressure equivalent t o  8500 meters, but t h e  oxygen pres- 
sure  is  60-percent grea te r  than t h a t  found a t  s ea  l e v e l .  
s tud ie s  before t h e  s tar t  of t h e  manned f l i g h t s  d id  not suggest that this 
atmosphere would cause changes i n  t h e  red-cell  mass - w i t h  one exception. 
Helvey ( r e f .  1-2), using hematocrit changes t o  estimate red-cell-volume 
changes, showed marked drops i n  hematocrit when 100 percent oxygen a t  
363 t o r r  was used. 
as a hemolytic process. 
Generally, 
He described t h i s  change, which occurred i n  48 hours, 
Red-cell-mass changes noted during s i x  missions a r e  shown i n  
t a b l e  1-111. A l l  s i x  astronauts i n  t h e  Gemini missions had a decrease 
i n  red-cell  mass. If t h e  quant i ty  of red c e l l s  l o s t  (an average of 
319 m i l l i l i t e r s )  i s  converted t o  quant i ty  of blood, each of t h e  s i x  
astronauts l o s t  approximately TOO m i l l i l i t e r s  of blood. 
Similar s tud ie s  were performed a f t e r  t h e  Apollo 7 ,  8, and 9 m i s -  
s ions.  
a g rea t e r  change than the percent change i n  f i v e  of the s i x  Apollo 7 
and 8 crewmembers. However, t h e  Apollo 9 crew percent changes are l e s s  
than those of the s i x  Gemini crewmembers. 
atmosphere w a s  s i g n i f i c a n t l y  g rea t e r  i n  t h e  Gemini missions than i n  t h e  
Apollo 7 and 8 missions. 
mediate value.) Nitrogen remained i n  the  Apollo 7 and 8 command module 
atmospheres. The nuclear-medicine study group be l ieves  that  t h e  presence 
of nitrogen may have moderated t h e  red-cell  loss observed i n  the Gemini 
missions. 
c r a f t  atmosphere u n t i l  a f t e r  the January 1967 command module f i r e .  
all missions s ince ,  a nitrogen-containing atmosphere has been used during 
the launch phase. A f t e r  l i f t - o f f ,  gas lo s ses  are replaced by oxygen s o  
that t h e  atmosphere gradually approaches 100 percent oxygen. Because 
t h e  dump rate i s  low, t h e  atmosphere never reaches 100 percent unless 
t h e  hatches are opened (as  was done half’way through t h e  Apollo 9 mission, 
but not on t h e  Apollo 7 and 8 missions).  
on the missions i n  which t h e  atmosphere d id  not include nitrogen a r e  
combined and compared with t h e  two missions i n  which nitrogen was present,  
a mean decrease i n  red-cell mass of 13 percent r e s u l t s ,  compared with a 
2.0-percent decrease f o r  those when nitrogen was present.  
are d i f f e r e n t  at the <0.01 l e v e l .  
The 7-percent mean decrease i n  the  t h r e e  Apollo 9 crewmembers i s  
The oxygen pressure i n  t h e  
(The Apollo 9 oxygen pressure w a s  of an in t e r -  
A s  m a y  be r eca l l ed ,  nitrogen w a s  not included i n  t h e  space- 
I n  
If t h e  red-cell-mass decreases 
These means 
Because no bleeding w a s  experienced, two mechanisms e x i s t  that could 
explain t h e  decrease i n  red-cel l  mass observed i n  t h e  Gemini and Apollo 9 
s tudies  - increased in t ravascular  des t ruc t ion  and decreased production 
rate.  
Certain o ther  s tud ie s  were performed t o  attempt an e t i o l o g i c a l  c l a s s i -  
f i c a t i o n  of the change. These included chromium-51 red-cell-survival 
s tud ie s ,  the  r e s u l t s  of which are shown i n  t a b l e  1 - I V .  The mean-red-cell 
half-times of the two Gemini missions and of t h e  Apollo 9 mission are 
shor t e r  than the expected or observed norms. 
ce r t a in ly  no evidence e x i s t s  of a difference between s i x  crewmembers and 
s i x  cont ro ls  f o r  t he  Apollo 7 and 8 missions,  i n  cont ras t  t o  the Apollo 9 
mission on which the lowest mean i s  observed. This difference suggests 
that a mild hemolysis occurred during the high-oxygen missions. However, 
t he  differences are s l i g h t .  
The da ta  are sketchy, but 
Several  explanations f o r  t h e  mild hemolysis observed on t h e  Gemini 
missions have been offered,  the most p laus ib le  of which suggests that  the 
hyperoxic environment produces a r e l a t i v e  tocopherol deficiency. 
oxygen tens ion  i s  known t o  cause red-cell  abnormalit ies.  
abnormalit ies have only been reported a t  oxygen tensions higher than 
100 percent oxygen a t  258 t o r r .  High-oxygen tensions are thought t o  cause 
hemolysis through peroxidation of membrane l i p i d s .  T h i s  e f f e c t  i s  counter- 
acted by vitamin E. Some evidence e x i s t s  t h a t  the astronauts '  prepackaged 
d i e t  w a s  s l i g h t l y  de f i c i en t  i n  tocopherol during the Gemini missions. 
Increased 
However, these 
. 
The plasma l eve l s  of vitamin E and vitamin A of the Apollo 9 crew 
and a cont ro l  group are shown i n  f igu re  1-2. The ground-based cont ro ls  
showed no change or an ac tua l  increase  i n  vitamin A during the mission, 
w h i l e  the crew showed decreases i n  both vitamins E and A,  an observation 
that tends t o  support t h e  pos tu la te  of a tocopherol deficiency. 
M i t h  decreased red-cel l  mass and decreased r e d - c e l l  su rv iva l ,  in- 
creased i r o n  turnover would be expected i f  the bone marrow were respond- 
ing t o  this stress. The iron-turnover da ta  obtained from t h e  Apollo 7 
and 8 missions are l i s t e d  i n  table 1-V. 
The crew had higher  serum i r o n s ,  slower half-t imes,  lower i r o n  turn- 
overs,  and lower percent reappearance. Although each of these values i s  
interdependent,  decreased bone-marrow a c t i v i t y  a t  t h e  t i m e  of recovery 
i s  suggested. These iron-study values suggest i nh ib i t i on  of bone-marrow 
funct ion rather than hemolysis. 
low-oxygen missions and t h e  da ta  may not be ind ica t ive  of the changes i n  
the G e m i n i  missions and t h e  Apollo 9 mission. 
However, t he  Apollo 7 and 8 f l i g h t s  were 
I * 
The degree t o  which these  volume changes a f f e c t  t h e  endocrine system 
Both a decreased plasma volume and a decreased red-cel l  are of i n t e r e s t .  
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mass at the time of recovery were observed. The red-cell-mass change 
has been associated w i t h  decreased red-cell  surv iva l  and r e l a t i v e l y  low 
i ron  k ine t i c s  a t  the time of recovery i n  low-oxygen missions. 
Fluid-Volume Changes 
In  addi t ion t o  decreased blood volume, the  crews exhibited decreased 
ex t r ace l lu l a r  f l u i d  volume and perhaps changed i n t r a c e l l u l a r  f l u i d  volume. 
A t  t he  t i m e  of re turn ,  the  crews weighed approximately 3 kilograms l e s s  
than they did a t  l i f t - o f f ;  about 67 percent of this weight l o s s  w a s  re- 
covered i n  t h e  first 24 hours after t h e i r  re turn.  
not regained i s  presumed t o  represent the  e f f ec t s  of the suboptimal ca lo r i c  
intake chosen by the crew. During tha t  time, they lo se  t h e i r  intolerance 
t o  lower-body negative pressure and recover most of t h e i r  exercise  to l e r -  
ance. "he 'profound weight loss  has not been seen i n  the  bedrest  s tud ies .  
Houever, mean ex t r ace l lu l a r  losses  of 1.1 l i t e r s  a t  4 days and 2.2 l i t e r s  
a t  t h e  end of 10  days of bedrest  have been measured. 
urements have not ye t  been made f o r  t h e  f l igh t  crews, t h e  crew weight 
losses  suggest that the ex t r ace l lu l a r  f l u i d  decreases more rap id ly  during 
a mission than during bedrest .  
The weight t h a t  was 
Although these  meas- 
Orthostat ic  intolerance would be expected when the crew re turns  t o  
a one-g environment, w i t h  decreased plasma volume as a contributory f ac to r .  
Ext race l lu la r  f l u i d  volume should be decreased, but it has not y e t  been 
measured. These volume changes should be associated w i t h  increased renin 
production, with increased epinephrine output,  and eventually with in- 
creased co r t i co id  production. Antidiuret ic  hormone a c t i v i t y  would in- 
crease. The r e s u l t s  of these changes would be water and sodium re ten t ion  
accompanied by a potassium diures i s .  
should the  blood sugar. 
have been observed with increased white-blood-cell counts and blood sugars,  
but  potassium d iu res i s  i s  absent. 
The white count should increase as 
Indeed, water re ten t ion  and sodium re t en t ion  
CONCLUDING REMARKS 
How the longer duration of the Skylab missions w i l l  a f f e c t  these  
parameters as the crews r e tu rn  t o  a one-g environment cannot be answered 
at this time. An addi t iona l  unknown i s  the e f f e c t s  of t he  l a r g e r  l i v i n g  
volume and t h e  exercise  planned fo r  t he  Skylab missions. No longer w i l l  
the crew be confined t o  their  couches as i n  the Mercury and Gemini mis- 
s ions.  
t he  ast ronauts  have never been assigned t h e  exercise  p r o f i l e  that should 
be one pa r t  of the Skylab Program. 
Although the  Apollo command module permits movement i n  t h e  cabin, 
This exercise  should allow them t o  
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maintain muscle s t rength ,  even on these  long-duration missions. How 
this exercise will a f f e c t  t h e  o r thos t a t i c  in to le rance  i s  unknown. 
It i s  i n t e r e s t i n g  t o  note t h a t  t h e  longest mission t o  da te ,  Gem- 
i n i  V I I ,  w a s  not assoc ia ted  with a decreased plasma volume; ye t  o ther  
changes c h a r a c t e r i s t i c  of o r t h o s t a t i c  in to le rance  were observed. The 
Skylab atmosphere w i l l  not be hy-peroxic, and, unlike the Gemini atmos- 
phere, w i l l  contain nitrogen. The exercise program should be an addi- 
t i o n a l  stimulus t o  maintain t h e  crew's red-ce l l  mass. It i s  expected 
t h a t  t hese  changes should moderate or  even prevent the red-cell-mass 
changes. 
min E. However, as was t h e  case with t h e  plasma-volume changes, whether 
this predic t ion  w i l l  be t r u e  w i l l  not be known u n t i l  t h e  Skylab da ta  a re  
analyzed. 
I n  addi t ion ,  the Skylab food w i l l  probably contain more v i t a -  
W i t h  respect t o  t h e  nuclear-medicine procedures scheduled f o r  t he  
Skylab missions, permission t o  perform t h e  s tud ie s  j u s t  described has 
been sought. I n  addi t ion ,  hopefully, the  t o t a l  body water, t o t a l  ex- 
changeable potassium, and e x t r a c e l l u l a r  space can be determined. These 
s tud ie s  w i l l  be designed t o  allow more p rec i se  i n t e r p r e t a t i o n  of t h e  
expected endocrine changes. 
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Mean change 
Plasma volume, ml . . . . . 
s Water Bed- 
immersion r e s t  
-563 -318 1 
I 
Vascular albumin, ml . . . 
Urine, ml . . . . . . . . . 
Hematocrit, percent . . . . 
s 
-53 -32 
935 674 
8 4 
i '  
TABLE 1-1.- CHANGES NOTED I N  
WEIGHTLFSSNESS SIMULATIONS 
TABLE 1-11.- PLASMA-VOLUME PERCENT CHANGE, 
APOLLO AND GEMINI MISSIONS 
Miss ion 
Gemini I V  
Apollo 8 
Gemini V 
Apollo 7 
Apollo 9 
Gemini V I 1  
Duration, 
days 
4 
7 
8 
11 
11 
1 4  
Ckange, percent 
Mean 
-8 
-13 
-7 
-3 
-8 
11 
Predicted 
-7 
-9 
-10 
-11 
-11 
-12 
Chair 
rest 
-151 
-2 
452 
3 
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TABLE 1-111.- RED-CELL-MASS PERCENT CHANGE, 
G E M I N I  AND APOLLO MISSIONS 
Mission 
G e m i n i  I V  
G e m i n i  V 
G e m i n i  V I 1  
Apollo 9 
Apollo 7 
Apollo 8 
C h a n g e ,  percent 
Astronaut 
D u r  at ion,  
days 
2 3 
-13 -- 
-22 - 
-a -- 
-7 -10 
-0 -9 
-2 -4 
M e a n  
-12 
-21 
-14 
-7 
-3 
-1 
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C r  eV 
18 
23 
' 24 
26 
3 1  
TABLE 1-1V.- MEAN RED-CELL SURVIVAL, GEMINI  
AND APOLLO M I S S I O N S  
[ H a l f - t i m e s  using chromium-511 
C o n t r o l  
-- 
- 
28 
16 
30 
M i s s i o n  
G e m i n i  V 
G e m i n i  V I 1  
Apollo 9 
Apollo 7 
Apollo 8 
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TABLE 1-V.- IRON KINETICS AT RECOVERY 
Parameters 
Serum i ron ,  pg . . . . . . . . 
Half-time, min . . . . . . . . 
Iron turnover,  mg/kg per 
body weight/day . . . . . . . 
Reappearance, percent . . . . . 
Crew 
105 i 6 
138 i 7 
-34 i .03 
86 i 2 
Controls I 
94 i 4 
112 2 5 
-41 i .03 
95 i 3 
+30 
+2 0 
c) c 
0) 
g +10 
- 5 0  
5 -10 
0 
l g  
m 
n 
m -
-2 0 
2.0 
1.5 
4.l 
I= 
0) 
2 
1.0 
s 
.5 
0' 
. 
= 
I 
I 
' 
c 
 
D 
I 
Preflight 
D 
Controls 
-30 
0 10 20 30 
Bedrest, days 
Figure 1-1.- Percent decrease 
i n  mean plasma volume during 
bedrest .  
0 
160 
120 
4 c 
Q 0
0) 
2 80 
3 
s 
2! 
rn .- -L 
P 
40 
0 
Controls Crew 
(a)  Plasma vitamin E. ( b )  Plasma vitamin A. 
Figure 1-2.- Plasma l eve l s  of vitamins E and A i n  cont ro l  group 
and i n  Apollo 9 crew. 
2-1 
2. HEMATOLOGY RESULTS ON G E M I N I  AND APOLLO MISSIONS 
By Craig L. Fischer,  M.D.* and Stephen L.  Kimzey, Ph. D. t 
c 
HEMATOLOGICAL PROGRAM 
The bes t  summaries of what w a s  known about red-cell  mass and plasma 
volume, after t h e  Gemini Program was terminated, a r e  contained i n  f ig-  
ures 2-1 and 2-2, respect ively.  
seem t o  s t a b i l i z e  by t h e  fourth day of space f l i g h t  and do not progress 
between t h e  fourth and t h e  eighth f l i g h t  days. 
i n  t h e  red-cel l  mass ( f i g .  2-1) does not seem t o  occur after t h e  eighth 
day, but  a compensatory increase (on at l e a s t  one Gemini mission) i n  
plasma volume occurred, such t h a t  t h e  p re f l igh t  blood volume w a s  regained 
by t h e  14th f l i g h t  day. I n  addition t o  these changes, t h e  observation 
w a s  made during t h e  Gemini Program tha t  t he  red-cel l  mass w a s  s i g n i f i -  
can t ly  decreased by space f l i g h t  and t h a t  t h i s  red-cell-mass decrease 
w a s  associated w i t h  an increase i n  t h e  mean corpuscular volume, an in- 
crease i n  the  osmotic f r a g i l i t y  of t h e  red-cel l  population, and an in- 
crease i n  t h e  pos t f l i gh t  re t icu locyte  counts. 
The plasma-volume changes ( f i g .  2-2) 
A s ign i f i can t  decrease 
The medical port ion of t h e  Apollo Program w a s  designed t o  inves t iga te  
i n  more d e t a i l  t h e  changes observed during t h e  Gemini Program. Some of 
t h e  medical da ta  obtained dur ing ' the  Apollo missions t o  date  are shown 
i n  t a b l e  2-1. The same types of hematological changes were expected i n  
t h e  Apollo Program as had been observed i n  t h e  Gemini f l ight  s e r i e s .  
Surpris ingly,  no decrease i n  t h e  red-cell  mass was observed during t h e  
Apollo 7 or  8 missions. 
A change i n  launch-atmosphere composition - from 100 percent oxygen 
t o  60 percent oxygen and 40 percent nitrogen at 260 t o r r  with cabin leak- 
age being replaced by oxygen - w a s  effected after t h e  t r a g i c  Apollo f i re .  
Therefore, t h e  Apollo 7 and Apollo 8 missions were characterized by an 
oxygen concentration t h a t  never c lose ly  approximated 100 percent;  
*Pathologist and Chief , Clin ica l  Laboratories , Manned Spacecraft 
tChief , Cell Analysis Laboratory, Manned Spacecraft Center , Houston, 
Center, Houston, Texas 77058. 
Texas 77058. 
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i n  f a c t ,  it reached only 90 t o  94 percent. 
changes i n  phosphofructokinase, hexokinase, and phosphoglyceric kinase 
were observed, these changes were not r e a l l y  in te rpre tab le .  Otherwise, 
no s ign i f i can t  changes were observed during the  Apollo 7 and 8 missions, 
other than t h e  s l i g h t ,  but s t a t i s t i c a l l y  s ign i f i can t ,  reduction i n  t h e  
epythpopoietic a c t i v i t y ,  as measured by fe r rokine t ic  s tud ies .  
Although some inconstant 
On the  Apollo 9 mission, t h e  crew opened t h e  spacecraft  hatches 
t o  perform extravehicular a c t i v i t y .  
sealed,  and pressurized w i t h  100 percent oxygen, t h e  crew denitrogenated 
and l i ved  i n  a pure-oxygen environment f o r  t he  remaining 4 t o  5 days. 
Even though crew denitrogenation began a t  t h e  t i m e  of repressurizat ion 
and the crew l ived  i n  100 percent oxygen f o r  t h e  next 5 days, only a 
7-percent mean decrease i n  crew red-cell  mass w a s  observed - a  signif- 
i can t ,  but not dramatic, change. However, t h e  crew was not denitrogen- 
a ted before t h e  mission as had been t h e  crews i n  t h e  Gemini Program. 
Gemini crewmen breathed 100 percent oxygen a t  760 t o r r  f o r  3 hours before 
the  mission, again on t h e  launch complex f o r  severa l  hours before l i f t -  
o f f ,  and then proceeded with a mission on which a 100-percent-oxygen, 
260-torr atmosphere w a s  used. Thus, t h e  Apollo 7 and 8 oxygen-nitrogen 
p ro f i l e s  d i f fe red  completely f r o m t h e  Gemini missions. Even t h e  atmos- 
phere p r o f i l e  of t h e  Apollo 9 mission differed considerably, although 
it w a s  somewhat similar t o  t h e  Gemini-type atmosphere p ro f i l e .  
After t h e  spacecraft  had been re- 
The Apollo 9 mission i s  discussed a t  length i n  t h i s  sec t ion ,  because 
it w a s  t h e  only Apollo mission on which 100 percent oxygen at 260 t o r r  
was used f o r  a s ign i f i can t  length of t i m e  and f o r  which de ta i l ed  s tudies  
are avai lable .  A decrease i n  t h e  re t icu locyte  count w a s  observed, but  
no opportunity exis ted t o  perform t h e  fe r rokine t ic  s tud ies .  
vations included a s ign i f i can t  loss  i n  red-cel l  mass, a s ign i f i can t  de- 
crease i n  plasma tocopherol vitamin E,  and a s ign i f i can t  decrease i n  
plasma vitamin A .  
( r e f .  2-1) at Ohio S t a t e  University. (On t h e  Apollo 10 ,  11, 12,  and 
13  missions, t he  100-percent-oxygen atmosphere was not used, and no de- 
creases i n  tocopherol and vitamin E were observed.) 
Other obser- 
Some changes i n  the  enzymes were measured by Mengel 
As shown i n  f igure  2-3, s ign i f i can t  decreases were observed a f t e r  
t h e  Apollo 9 mission i n  t h e  plasma vitamin E and vitamin A l e v e l s ,  as 
compared with th ree  controls .  The reductions i n  t h e  plasma vitamin E 
a re  s t a t i s t i c a l l y  s ign i f i can t .  Concomitant changes i n  t h e  red-cell- 
membrane vitamin E o r  vitamin A were not observed. 
Total  phospholipid, neu t r a l  l i p i d ,  and f a t t y  acids of severa l  major 
phospholipids of t h e  red-cel l  membrane were measured. 
l e c i t h i n  t o t a l s  (as measured by thin-layer separat ion)  of t h e  Apollo 9 
crew and t h e  controls  are shown i n  f igu re  2-4. No s ign i f i can t  changes 
were noted i n  the  controls ;  however, a very marked change i n  t h e  red- 
cell-membrane l e c i t h i n  l eve l s  of t h e  oxygen-exposed crew w a s  observed. 
The red-cel l  . 
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This very s ign i f i can t  change w a s  not r e l a t ed  t o  d i e t .  
pa t te rns  of t h i s  phospholipid and others show a shortening of the f a t ty -  
acid chains , paxt icu lar ly  t h e  long-chain , unsaturated f a t t y  acids  , such 
as C24, C22 , and c18. In  other  words , what was observed i s  compatible 
with l i p i d  peroxidation. Thus, not only w a s  there  a quant i ta t ive  change 
i n  t h e  phospholipids but  a l so  a qua l i t a t ive  change i n  the f a t t y  acids  of 
t he  phospholipids. Evidently both changes can be explained on t h e  basis 
of peroxidation. 
The fat ty-acid 
. 
On the  same mission, the sodium-potassium f lux  on t h e  red c e l l  was 
s tudied;  t h e  results are shown i n  f igure  2-5. Before t h e  mission, imme- 
d i a t e l y  afterward, and 1 day a f t e r  recovery, t h e  controls  showed essen- 
t i a l l y  no change, but  a s ign i f i can t  reduction i n  t h e  ac t ive  component of 
potassium f l u x  w a s  observed i n  t h e  oxygen-exposed f l i g h t  personnel. 
ac t ive  cat ion t ranspor t  was measured. 
vere problem, t h e  passive limb of cat ion t ransport  was not studied. 
Only 
Only because l o g i s t i c s  are a se- 
In  summary, t h e  Apollo 9 data  indicated reductions i n  plasma 
tocopherol, plasma vitamin A ,  and severa l  major red-cel l  phospholipids. 
Leci thin,  which is  a major component of t h e  red-cell  membrane, not only 
showed a dramatic change quant i ta t ive ly ,  but qua l i t a t ive ly  as w e l l .  
reduction i n  t h e  ac t ive  cat ion t ranspor t  of red c e l l s  was a l so  observed 
after t h e  Apollo 9 mission. 
A 
With respect  t o  t h e  ove ra l l  Apollo hematological program (table 2-11), 
no s ign i f i can t  red-cell-mass changes were observed after t h e  Apollo 7 
and 8 missions; however, a modest but s ign i f icant  loss  of red c e l l s  w a s  
observed after t h e  Apollo 9 mission, presumably as a result of t h e  d i f -  
fe ren t  spacecraf t  atmosphere. The s igni f icant  reduction of red-cel l  mass 
after t h e  Apollo 9 mission was associated w i t h  decreases i n  plasma 
tocopherol and vitamin A. Decreases i n  red-cell-membrane phospholipid 
content and i n  the  ac t ive  sodium-potassium f lux  of t h e  c e l l s  were a l s o  
observed. Morphologic changes (acanthocytes) w e r e  shown by w e t - c e l l  
preparations and phase microscopy. Such changes a r e  w e l l  known; Ways 
and Hanahan ( r e f .  2-2) have reported t h a t ,  i n  acanthocytes, a l t e r a t i o n  
of t h e  sphingomyclin-to-lecithin r a t i o  occurs, as well  as qua l i t a t ive  
changes i n  t h e  phospholipids of t he  red-cel l  membrane. Again, t h e  d i f -  
ference between t h e  Apollo 9 data  and t h e  Apollo 7 and 8 da ta  i s  oxygen 
o r  atmosphere r e l a t ed .  
A l l  t h e  da t a  are in tegra ted  i n t o  a hypothesis t ha t  i s  diagramed i n  
f igure  2-6, which includes the  Jacob's model ( r e f .  2-3) of heredi ta ry  
spherocytosis,  some of the work by Mengel ( r e f .  2 - l ) ,  and some of t he  
concepts t h a t  have evolved a t  t h e  Manned Spacecraft Center (MSC) labo- 
ra tory .  Figure 2-6 is  not necessar i ly  o r ig ina l ,  but it i s  a synthesis 
of already proven and accepted concepts presented i n  t h e  manner t h a t  
seems t o  f i t  t h e  MSC data  bes t .  
peroxidation of the  red-cell-membrane l i p i d s ,  as Mengel ( r e f .  2-1) has 
It is  believed t h a t  hyperoxia causes 
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shown. This peroxidation of red-cell-membrane l i p i d s  can cause one of 
several  r e s u l t s .  (1) The plasma vitamin E and vitamin A l eve l s  can be 
reduced j u s t  by v i r tue  of t he  f a c t  t h a t  these  s t e r o l s  are  l i p i d  an t i -  
oxidants and a re  consumed i n  t h i s  type of react ion.  ( 2 )  Peroxidated 
l i p i d s  can physical ly  compromise red-cell-membrane in t eg r i ty .  Lipid 
peroxides are very e f f ec t ive  and e f f i c i e n t  red-cell-membrane sulfhydryl-  
group inh ib i t e r s .  Thus, i f  red-cel l  l i p i d  peroxides were formed, inhi-  
b i t i o n  of red-cell-membrane sulfhydryl groups could be expected. The 
sulfhydryl groups are qui te  important i n  maintaining t h e  i n t e g r i t y  of 
passive red-cell-membrane cat ion t ranspor t .  If ac t ive  cat ion t ranspor t  
i s  poisoned by the  same mechanism, one would observe osmotic swelling 
of t he  red c e l l s  r e su l t i ng  i n  attainment of c r i t i c a l  volume and l y s i s .  
Thus, a l t e r ed  ac t ive  and passive transmembrane cat ion t ranspor t  may be 
occurring simultaneously. Because t h e  data f i t  t he  hypothesis so  w e l l ,  
it i s  believed t h a t  t he  hemolytic event has been described accurately 
and t h a t  it i s  oxygen r e l a t ed .  
P.ersonne1 a t  the  MSC Cl in ica l  Laboratories have functioned as a 
Federal resource group and have had t h e  opportunity t o  apply a very com- 
prehensive hematological evaluation i n  several  areas, such as space 
f l ight ,  undersea exploration, and vacuum-chamber tes ts ,  t o  name jus t  a 
few. 
the  same techniques i n  d i f f e ren t  environments. The supported programs 
included Tekt i te  I and 11, the  Apollo 7 ,  8, and 9 missions, an MSC 
vacuum-chamber t e s t  ca l l ed  2TV-1, two Brooks A i r  Force Base chamber 
tests,  a Sealab I11 chamber t e s t ,  and t h e  Gemini I V ,  V ,  and V I 1  missions. 
I n  table 2-111, these t e s t s  are ranked according t o  the  mean red-cell-  
mass loss  t h a t  was measured i n  the  subjects .  These data include t h e  
percent loss  , t he  atmosphere composition, t he  number of subjects  , and 
the  exposure duration. What is  noteworthy i s  t h a t ,  anytime a 100-percent- 
oxygen atmosphere w a s  used, s ign i f i can t  red-cell-mass loss occurred. 
Anytime any d i luent  gas w a s  present (pa r t i cu la r ly  ni t rogen)  , no s ign i f -  
i can t  red-cel l  loss  was observed. This e f f ec t  suggests a pro tec t ive  
e f fec t  of ni t rogen,  more spec i f i ca l ly  an ac t ive  mechanism. 
The same protocol was performed by the  same inves t iga tors  using 
Several nitrogen e f f ec t s  can be c i t e d  from t h e  l i t e r a t u r e .  Nitrogen 
i s  known t o  pa r t i c ipa t e  ac t ive ly  i n  the  formation of c l a th ra t e s  and 
l i q u i d  c r y s t a l s  and, thus ,  can s t a b i l i z e  red-cell-membrane water. The 
phenomenon can be thought of i n  terms of molecules of water becoming more 
organized and more ordered and, thus ,  more r e s t r i c t e d  i n  t h e i r  degrees of 
freedom. Such an occurrence would be d i r e c t l y  r e l a t ed  t o  membrane t rans-  
po r t ,  which i s  a physical-chemical phenomenon. 
gen provides a pro tec t ive  mechanism i n  red-cell-mass loss  cannot be 
defined y e t ,  but  it i s  evident t h a t  nitrogen i s  protect ive.  
The extent t o  which n i t ro-  
It a l so  appears t h a t  tocopherol i s  protect ive.  Several methods t o  
t e s t  t h i s  hypothesis e x i s t ,  when t h e  basic  mechanisms are understood. 
Tocopherol w i l l  not be a l imi t ing  f a c t o r ,  even i f  a 100-percent-oxygen 
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atmosphere must be used f o r  long periods of time. However, appropriate 
immediate act ion could be taken t o  avoid any problems tha t  might arise. 
Thus , one of t h e  more in t e re s t ing  findings , i f  it proves t r u e ,  of the  
MSC hematology program i s  the  very s t rong,  pro tec t ive ,  ac t ive  e f f e c t  of 
nitrogen, which has always been ca l l ed  a nerve gas. 
BIOCHEMICAL PROGRAM 
. 
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Some of t h e  biochemical data  f o r  the Apollo 7 t o  13 missions a re  
shown i n  table 2-1. Each arrow represents a standard deviation. The 
overa l l  pos t f l i gh t  data  f o r  t h e  missions a re  p lo t t ed  i n  t h e  right-hand 
column. 
therefore ,  it may not be accurate t o  p lo t  t h e  overa l l  t rend  i n  t h i s  
manner. The only consis tent  t rend i s  a s igni f icant  pos t f l i gh t  increase 
i n  t r u e  serum glucose, which is  believed t o  be an epinephrine-related 
event. This increase i s  t r ans i en t  and usual ly  disappears by t h e  t i m e  
of t h e  next blood sampling (usual ly  12 t o  24 hours l a t e r ) ,  when t h e  glu- 
cose is usually normal. 
t he  serum cholesterol  and u r i c  ac id ,  which may be r e l a t ed  t o  d i e t  i n  t h a t  
t h e  crews a re  ea t ing  a b e t t e r  d i e t  during t h e  missions than they do nor- 
mally. This decrease i s  very s l i g h t ,  but s ign i f icant  a t  t h e  l e v e l  of 
one standard deviation. A consis tent  change i n  serum crea t in ine  was 
observed on only two missions. Whether t h i s  decrease ind ica tes  some 
a l t e r a t i o n  of r ena l  clearance o r  not i s  not known, because, unfortunately,  
renal-clearance t e s t s  a r e  not current ly  performed aboard the recovery 
ship. 
It must be remembered that  the  mission p ro f i l e s  d i f f e r  and, 
An apparent consis tent  decrease i s  observed i n  
With respect  t o  isoenzymes, although the  changes are somewhat incon- 
s i s t e n t ,  a s l i g h t  ove ra l l  decrease i n  l a c t i c  dehydrogenase (LDH) 4 and 
a s l i g h t  increase i n  LDH 5 were observed. These changes may be r e l a t e d  
t o  l o g i s t i c s  of sample s t a b i l i z a t i o n  and are  only apparent. 
enzyme exhibi ted t h i s  change. It is i n t e re s t ing  t o  note t ha t  hemolysis 
was experienced on the  Apollo 9 mission, The LDH R i s  a red-cel l - re la ted 
isoenzyme; t h i s  isoenzyme w a s  elevated by three o r  more standard devia- 
t i ons  on t h e  Apollo 9 mission. 
at a l l ,  on the other  missions. Sodium, potassium, chlor ide,  and osmola- 
l i t y  do not seem t o  show any consis tent  changes. Sometimes, s ign i f i can t  
increases  occurred; sometimes, s ign i f i can t  decreases. The t o t a l  protein 
and electrophoret ic  pat terns  ind ica te  some t rends ,  bu t  t he  t rends are 
very d i f f i c u l t  t o  i n t e rp re t .  Changes i n  glucose, choles te ro l ,  u r i c  ac id ,  
LDH 4, and LDH 5 were observed; these  changes may be l o g i s t i c a l l y  r e l a t ed .  
Two epinephrine-related f ac to r s  - absolute neutrophi l ia  and red-cel l  
changes - have been reported.  
No other  
The LDH R i s  not qu i te  as elevated, i f  
In  summary, t he  biomedical da ta  a re  not s ign i f i can t ly  he lp fu l ,  no 
The least tha t  can be sa id  object ively matter how de ta i l ed  t h e  study. 
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with cer ta in ty  i s  t h a t  no s ign i f i can t  changes i n  t h e  serum biochemistry 
occurred. Alkaline-phosphotase isoenzymes and iodized calciums w i l l  be 
measured f o r  the  f irst  time on the  Apollo 1 4  mission. 
be of i n t e r e s t  i n  r e l a t ion  t o  the  bone-mobilization c lus t e r .  
These da ta  w i l l  
The Apollo Program biochemical data  ind ica te  t h e  following. 
1. A pos t f l i gh t  hyperglycemia i s  regular ly  observed as the  r e s u l t  
of an increased re lease  of catecholamines t h a t  are secondary t o  the  
s t r e s s  of entry.  
2. Serum-cholesterol and uric-acid l eve l s  generally decline during 
the  f l i g h t s ,  presumably as t h e  result of t h e  f l i g h t  d ie t .  
3. A t r ans i en t  pos t f l i gh t  decrease i n  LDH 3 (associated with an 
increase i n  LDH 4 )  i s  of'ten observed. 
4. A transient,  pos t f l i gh t  decrease i n  t o t a l  serum carbon dioxide 
has been observed i n  t h e  one crew (Apollo 13)  t e s t ed  f o r  t h i s  parameter. 
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Cholesterol 
Serum glutamic-oxalacetic 
Blood urea nitrogen 
Uric acid 
Alkaline phosphatase 
Calcium 
Magnesium 
Inorganic phosphate 
Total b i l i rub in  
Creatinine 
Creatinine phosphokinase 
Lactic dehydrogenase (LDH)  
English nomenclature 
LDH ’ t  2 fraction 
LDH 3 
LDH 4 
LDH 5 - Liver f rac t ion  
transaminase 
Heart 
Sodium 
Potassium 
Chlorine 
Osmolality 
Total protein 
Albumin 
Alpha 1 
Alpha 2 
Beta 
GaamVr 
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TABLE 2-11.- FADIOISOTOPE-HEMATOLOGY - APOLLO PROGRAM 
Parameter 
Plasma volume 
Red-cell m a s s  
Ferrokinet ics  
1 4  
51Chromium surv iva l  
Active red-cel l  sodium- 
Carbon-glycine surv iva l  
potassium f lux  
Passive red-cel l  sodium- 
potassium f lux  
Mis s ion 
-- 
Parameter t rend  
bt 
t 
-- 
0 
+ 
t 
0 C 
a 
b t l a  negative deviation. 
t i20 negative deviation. 
c Technically uns a t  i s factory data. 
. 
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Exposure period, 
d 4 *  
60 
7 
11 
TABLE 2-111. - 51CHROMIUM RED-CELL-MASS DATA 
percent 
RMge 
4 . 0  t o  -7.4 
+2.0 t o  -4.0 
-2.0 t o  -9.0 
~ ~~ 
Study o r  misrion 
10 
30 
4 
14 
8 
14 
Tekti te  I 
-4.0 t o  -10.0 
-7 t o  -22 
-12.0 t o  -13.0 
-8.0 t o  -19.0 
-20.0 t o  -22.0 
-19 t o  -31 
Apollo 6 
Apollo 7 
2w-1 
Brooks A i r  Force Base 
chamber study 
%dab I11 
chamber study 
Apollo 9 
Brooks A i r  Force Base 
chamber study (1970) 
Gemini XV 
Gemini VI1 
Gemini V 
Philadelphia chamber 
study (Tekt i te  11) 
Atmospheric p r o f i l e  
Pressure range, t o r r  
160 
876 
237 t o  304 
21 t o  456 
237 t o  304 
21 t o  456 
'237 t o  304 
21 t o  456 
236 
23 
209 
836 
12 887 
258 t o  304 
0 t o  456 
260 
288 
258 
258 
158 
2 882 
Oxygen 
Oxygen 
Nitrogen 
Oxygen 
Nitrogen 
Oxygen 
Oxygen 
Nitrogen 
Oxygen 
Nitrogen 
Helium 
OwBen 
Nitrogen 
Nitrogen 
Nitrogen 
Oxygen 
Oxygen 
Oxygen 
Oxygen 
Oxygen 
Nitrogen 
Number 
Of 
iubjects  
4 
3 
3 
3 
4 
3 
3 
8 
2 
2 
2 
6 
11 
21 
12 
-1.6 to -7.3 
+6.0 t o  -10.0 
*b.O t o  -9.0 
- 
Mem - 
-2.0 
-2.0 
-3.0 
-3.0 
-3.0 
-5.0 
-7.0 
-12.7 
-13.0 
-14.0 
-21.0 
-27.0 
- 
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Figure 2-1.- Gemini Program red-cell-mass 
data. 
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Figure 2-2.- Gemini Program plasma-volume data. 
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3. REVIEW OF ENDOCRINE RESULTS: 
PROJECT MERCURY, G E M I N I  PROGRAM, AND APOLLO PROGRAM 
By Carolyn S. Leach, Ph. D.* 
PROJECT MERCURY 
c 
When Project  Mercury w a s  i n  the  planning s tages ,  the hazards and 
s t r e s s e s  of space f l i g h t  were unknown quan t i t i e s .  Because the  adrenal  
gland i s  evident ly  one of t he  body's major responders t o  s t r e s s ,  it w a s  
na tu ra l  t o  include the  responses of t h i s  gland among the physiological  
parameters t o  be evaluated. 
Considering t y p i c a l  data  co l lec ted  on Mercury crewmen, ( f i g .  3 - l ) ,  
one can observe changes i n  the plasma 17-hydroxycorticosteroid concen- 
t r a t i o n .  It i s  of i n t e r e s t  t o  note the  comparison of the  changes ob- 
served after f l i g h t  t o  changes after rout ine exercise  i n  the p r e f l i g h t  
period. 
. D r .  Weil-Malherbe s tudied the  catecholamine excret ion rates of the  
Mercury crews. These measurements were made during periods f r e e  from 
imposed s t r e s s ,  during s t r e s s f u l  t r a in ing  procedures, and f i n a l l y  during 
and after space f l i g h t .  Increased excret ion rates of substances meas- 
ured, ind ica t ing  an ac t iva t ion  of the  sympathoadrenal system, were 
observed after t r a i n i n g  procedures on some occasions; bu t ,  on o thers ,  
the  same procedures were to l e ra t ed  without a s ign i f i can t  sympathoadrenal 
response. I n  the  same way, space f l i g h t  induced increased excret ion 
rates i n  some p i l o t s  but not i n  others .  I n  the  cases s tudied,  t he  sub- 
s tance t h a t  w a s  most f requent ly  excreted at s ign i f i can t ly  increased r a t e  
was epinephrine (ref.  3-11, 
8 
A t  the  completion of Pro jec t  Mercury, endocrine data ind ica ted  that  
space f l i g h t  evoked changes i n  catecholamines and 17-hydroxycorticosteroids. 
I n  both areas, changes caused by t h e  mission were equal t o  o r  l e s s  than 
changes observed a f t e r  t r a i n i n g  procedures. 
Project  Mercury had demonstrated impressively t h a t  man could survive 
and f'unction ably as a pilot/engineer/experimenter i n  t h e  space 
*Head, Endocrine Laboratory , Clin ica l  Laboratories , Manned Space- 
c r a f t  Center , Houston , Texas 77058. 
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environment f o r  periods of as long as 34 hours without undesirable reac- 
t i ons  o r  detriment t o  normal body functions.  
gained included t h e  f a c t  t h a t  no evidence of abnormal sensory or psycho- 
l o g i c a l  response w a s  observed during an o r b i t a l  space f l i g h t  l a s t i n g  as 
long as 1.5 days. However, a f t e r  missions of 9- and 34-hour durations,  
an o r t h o s t a t i c  r i s e  i n  hea r t  r a t e  and decrease i n  blood pressure were 
noted t h a t  pe r s i s t ed  f o r  7 t o  19 hours after landing. The changes a f t e r  
t he  34-hour mission were of g rea t e r  magnitude than those after t h e  9-hour 
mission, but a l l  changes disappeared i n  a similar time i n t e r v a l  i n  both 
cases. The implications of t h i s  hemodynamic response obviously would 
require ser ious  study before longer space missions. No o ther  c l ea r ly  
s ign i f i can t  changes were found i n  t h e  comprehensive p r e f l i g h t  and post- 
f l i g h t  physiological examinations. 
Other medical knowledge 
Basic questions concerning space medicine remained unresolved. Cer- 
t a i n l y  one of t h e  most outstanding questions concerned t h e  possible ef- 
f e c t s  of prolonged weightlessness and combined s t r e s s e s  upon the  
astronauts.  
G E M I N I  PROGRAM 
The biomedical program t h a t  evolved f o r  t h e  Gemini Program was de- 
signed with t h e  i n t e n t  of determining, by the  analysis of b io log ica l  
f l u i d s ,  t he  metabolic cost  of manned space f l i g h t .  The results of these  
biochemical analyses were used as indica t ions  of t h e  physiological s t a t u s  
of t h e  astronaut.  Where changes were found t o  occur, e f f o r t s  were made 
t o  understand the  causative mechanisms and t o  assess t h e i r  s ign i f icance  
r e l a t i v e  t o  the  space f l i g h t .  The measurements can be divided i n t o  
th ree  pa r t s .  The f irst  pa r t  cons is t s  of p r e f l i g h t  co l lec t ion  of ur ine  
samples and whole blood from each crewman t o  e s t a b l i s h  base-line values 
f o r  t he  ind iv idua l ;  t h e  second portion of t h e  measurements i s  the  assess- 
ment of t he  physiological s t a t u s  of t h e  crewmen using ana lys i s  of urine 
samples co l lec ted  i n f l i g h t ;  and ur ine  and blood samples co l l ec t ed  imme- 
d i a t e l y  pos t f l i gh t  a r e  used f o r  t he  f i n a l  portion. Within t h i s  context,  
a s e r i e s  of biochemical determinations w a s  performed, cons is t ing  essen- 
t i a l l y  of f l u i d  and e l e c t r o l y t e  balance, hormonal s t u d i e s ,  and correla- 
t i o n  of t he  two (ref.  3-2). 
. 
. , The da ta  co l lec ted  on the  Gemini V,  V I ,  and V I 1  missions are shown 
i n  f igu re  3-2. The p re f l igh t  values a re  considered t o  be 100 percent 
and the  pos t f l i gh t  values a re  compared with t h e  p r e f l i g h t .  The p o s t f l i g h t  
changes t h a t  have been a t t r i b u t e d  t o  t h e  space-fl ight environment a re  . 
e a s i l y  observed. 
U . S .  space f l i g h t .  This mission w a s  a l s o  the  only one on which complete 
co l lec t ion  of i n f l i g h t  urine samples has been attempted. 
To date, t h e  Gemini V I 1  mission has been the  longest 
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L 
An in-depth calcium-balance study was conducted by D r .  G. Donald 
Whedon, with endocrine parameters considered by D r .  Harry S. Lipscomb 
( r e f .  3-3). 
catecholamine increases  t h a t  continued f o r  24 hours a f t e r  t h e  missions. 
The 17-hydroxycorticosteroid values were low during the  14-day o r b i t a l  
mission but were elevated i n  the  f i r s t  day a f t e r  recovery. These find- 
ings are discussed i n  d e t a i l  i n  sect ion 10 of t h i s  repor t .  Other endoc- 
r ine  and e l ec t ro ly t e  da ta  were col lected before and a f t e r  the Gemini VI11 
and I X  missions ( ref .  3-4). The r e s u l t s  are  s imi la r  t o  those observed 
on the  Gemini VI1 mission. 
The major endocrine changes reported include i n f l i g h t  
APOLLO PROGRAM 
The endocrine program developed t o  support t he  medical requirements 
for  the Apollo missions w a s  constrained by the  l imi t a t ion  t o  p re f l igh t  
and pos t f l i gh t  t e s t i n g ,  so no i n f l i g h t  samples have been returned f o r  
analysis .  
To consider which hormones warranted thorough study i n  r e l a t ion  t o  
man i n  the  space-flight environment, t he  endocrine program was establ ished 
and i s  current ly  being implemented i n  two spec i f i c  areas under the  broad 
t i t l e  Neuroendocrine Control of the Adaptation t o  Space F l ight .  
two areas of study are  (1) the  quant i f icat ion of stress by the measure- 
ment of adrenal c o r t i c a l  and medullary hormones w i t h  t he  consideration 
of the  e f f ec t  of time and p i t u i t a r y  st imulation on these adrenal secre- 
t i ons  and ( 2 )  t he  endocrine cont ro l  of f l u i d  and e l ec t ro ly t e  balance. 
The 
Adrenal Response 
F i r s t ,  with regard t o  adrenal secret ions,  one can observe tha t  the 
catecholamine responses (figs. 3-3 and 3-4) during the  missions consid- 
ered are much l i k e  those noted i n  the Mercury and Gemini data. 
nephrine and norepinephrine concentrations are  generally increased i n  the  
f irst  24 hours after the  mission. 
rate i s  s t i l l  l o w  f o r  s t a t i s t i c a l  confirmation, t h a t  epinephrine i s  more 
sens i t i ve  t o  the  stress of space f l i g h t .  The plasma- and urinary- 
hydrocortisone data ( f i g s .  3-5 and 3-6) ind ica te  a s t r i k i n g  and unex- 
plained phenomenon i n  the  immediate-postflight sampling. It i s  evident 
t h a t  t h e  plasma-hydrocortisone values a re  below p re f l igh t  values i n  the 
blood sample taken within 3 hours after splashdown. However, the  in te -  
grated ur ine sample, col lected t h e  f irst  24 hours a f t e r  recovery, shows 
a general  increase i n  the  excretion of hydrocortisone. These r e s u l t s  
were not an t ic ipa ted  because the  hydrocortisone w a s  expected t o  increase 
a f t e r  space f l i g h t .  A f t e r  t h i s  f inding was noted, adrenocorticotrophic 
hormone (ACTH) was measured i n  the  immediate-postflight blood sample taken 
The epi- 
It a l so  appears, though the  sampling 
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from the Apollo 8 crewmen. The r e s u l t s  ( t a b l e  3-11 did not ind ica te  any 
s igni f icant  change from p re f l igh t  values.  However, it i s  necessary t o  
I consider the  extremely short  b io logic  h a l f - l i f e  of ACTH; and the  possi- 
b i l i t y  e x i s t s  t h a t  t h i s  blood sample was not taken i n  time t o  observe a 
b i l i t y  of time influence upon adrenal a c t i v i t y  w a s  considered; t h a t  i s ,  
i f  the  p re f l igh t  blood samples were taken i n  the  morning, the  values 
could be higher than samples taken i n  the  afternoon. However, the  launch 
and recovery times were compared ( t a b l e  3-11] and t h i s  f ac to r  does not 
appear t o  be the  reason fo r  t he  decreased pos t f l i gh t  plasma-hydrocortisone 
value. Other p o s s i b i l i t i e s  a r e  now being considered. 
I change from normal. I n  an attempt t o  i n t e r p r e t  t h i s  f inding,  t he  possi- 
Fluid and Elec t ro ly te  Balance 
The second major a rea  being s tudied i n  the  endocrine program i s  the  
control  of f l u i d  and e l ec t ro ly t e  balance by the  endocrine system. This 
pa r t  of t he  program w a s  es tab l i shed  fo r  two reasons. F i r s t ,  experience 
gained from Mercury, Gemini, and ea r ly  Apollo missions indicated dynamic 
pos t f l i gh t  changes i n  hormones ac t ive  i n  fluid and e lec t ro ly t e  control .  
The second reason w a s  t he  physical and c l i n i c a l  cha rac t e r i s t i c s  of t he  
crewmen returning from space f l i g h t .  For these reasons, t he  laboratory 
personnel have considered the p ro f i l e s  of f l u i d  and e l ec t ro ly t e  balance 
as r e l a t ed  t o  the  loss  i n  body weight tha t  cons is ten t ly  occurs during 
space f l i g h t  and have cor re la ted  these weight changes t o  a l t e r a t ions  i n  
body-fluid d i s t r ibu t ion  and the  e l ec t ro ly t e  compartments. 
Body-fluid losses  i n  crewmen ,on United S ta t e s  and Russian manned 
space f l i g h t s  have been cons is ten t ly  infer red  by a 2.5- t o  5-percent 
decrease i n  pos t f l i gh t  body weight ( t a b l e  3-111). This loss averages 
6 lb/crewman w i t h  over 50 percent of the  weight regained within the f i r s t  
24 hours a f t e r  splashdown. On those missions on which plasma volume w a s  
measured, a pos t f l i gh t  decrease has generally been observed. 
With these body weight changes used as ind ica tors  of f l u i d  changes, 
a study w a s  undertaken t o  consider the cat ions and anions t h a t  serve 
c r i t i c a l  ro l e s  i n  the  homeostatic regulat ion of blood volume. The 
urinary- and plasma-electrolyte values demonstrated s ign i f i can t  and con- 
s t a n t  changes i n  some spec i f i c  ions.  Plasma sodium and potassium values 
demonstrate a decreasing t rend  i n  the  f irst  pos t f l i gh t  sample with no 
r e a l  consistency i n  the  plasma chlor ide.  The urine samples co l lec ted  
the  f irst  24 hours a f t e r  recovery provide data demonstrating the  reten- 
t i o n  of sodium and chlor ide.  To a i d  i n  the  understanding of water and 
e l ec t ro ly t e  balance and rena l  funct ion,  the  hormone vasopressin ( the  
an t id iu re t i c  hormone (ADH) from the  pos te r ior  lobe of t he  p i t u i t a r y )  and 
the  adrenal mineralcort icoid (aldosterone)  were measured i n  t h e  ur ine.  
. 
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The urinary ADH values ( f i g .  3-7) demonstrate an increase i n  the  
These immediate postrecovery 24-hour sample f o r  most of the  crewmen. 
numbers co r re l a t e  very w e l l  with the observed weight l o s s  of these 
crewmen, ind ica t ing  tha t  the  weight loss i s  probably f l u i d  r e l a t ed .  
urinary-aldosterone values ( f i g s .  3-8 and 3-9) have been general ly  in-  
creased. It i s  of i n t e r e s t  t o  note tha t  t he  increase does not occur 
u n t i l  the  second pos t f l i gh t  day on some of the crewmen studied.  
The 
To pursue t h e  inves t iga t ion  one more s t e p ,  t he  plasma w a s  examined 
f o r  angiotensin I - a d i r e c t  ind ica t ion  of renin a c t i v i t y  - t o  ascer- 
t a i n  the  r o l e  of t he  kidneys i n  the  aldosterone response. 
( f i g .  3-10) demonstrate a s ign i f i can t  increase i n  most of the  crewmen. 
These very s ign i f i can t  values ind ica te  t h a t  the  kidneys a re  responsive 
t o  the  change i n  e f f ec t ive  blood volume being presented t o  them. 
These data 
After  these  data have been examined and the  f a c t  has been taken i n t o  
account t h a t  no c l i n i c a l  conditions associated w i t h  space f l i g h t  have 
occurred t h a t  could be a t t r i b u t e d  t o  the  f l u i d ,  e l e c t r o l y t e ,  and endoc- 
r i n e  changes, a schema proposing an adaptation t o  the  weightlessness 
environment ( r e f .  3-5) i s  presented ( f i g .  3-11). 
It is  bel ieved t h a t ,  while t he  crewman i s  i n  a weightless state,  
h i s  blood volume i s  evident ly  r ed i s t r ibu ted  pa r t i cu la r ly  from the lower 
extremit ies  i n t o  the  abdomen and thorax and tha t  t h i s  s i t u a t i o n  i n i t i a t e s  
a diuresis t h a t  has been described by Gauer and Henry ( r e f .  3 - 6 ) .  This 
d iu re s i s  i s  checked by an aldosterone response t h a t  would cause a sodium 
re ten t ion  and a se l ec t ive  potassium l o s s  -such as were observed i n  the 
Gemini V I 1  crewmen. Because these  changes were observed on the  only mis- 
s ion  on which t h e  opportunity f o r  inves t iga t ion  ex i s t ed ,  the proposed 
schema i s  not all j u s t  postulated.  Af'ter t h i s  adaptation, t h e  crewmen 
a re  i n  f l i g h t  i n  a new steady-state condition i n  which a lower t o t a l -  
body-water content and a lower total-body-potassium content a r e  experi- 
enced. If t h i s  s i t u a t i o n  indeed reaches s ign i f i can t  proportions the 
crewmen's bodies then exchange hydrogen ions t o  prevent further K 
r e s u l t i n g  i n  an i n t r a c e l l u l a r  acidosis .  This s i t u a t i o n ,  of course, 
would result i n  real compensations that  do not appear i n  the  proposed 
schema, but t h a t  would override the immediate resp i ra tory  response. The 
point  i s  that  a decrease i n  t o t a l  body potassium occurs tha t  sets the  
stage f o r  i n t r a c e l l u l a r  acidosis  and ex t r ace l lu l a r  hypokalemic a lka los i s .  
A s  much as a 20-percent pos t f l i gh t  decrease i n  t o t a l  body potassium has 
been measured, by low-level total-body-counter monitoring of the  t o t a l  
body potassium-40. Also, the returning crewmen's bodies r e t a i n  potassium 
and sodium f l u i d s  so t h a t  these p a r t i c u l a r  aspects of t he  schema a r e  
evident ly  appropriate.  It i s  i n t e r e s t i n g  t o  note tha t  some pos i t i ve  
feedback loops a re  proposed i n  the  schema. Once t h i s  chain of events 
begins,  a decrease i n  t o t a l  body potassium follows; of course, some l o s s  
+ 
loss, 
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of potassium i n  the  ur ine r e s u l t s ,  leading t o  a pos i t ive  feedback system 
t h a t  can be dangerous i f  t he  body i s  not provided with both potassium 
and chloride ions.  
CONCLUSION 
It should be emphasized t h a t  t he  problem of endocrine control  of 
f l u i d  and e l ec t ro ly t e  ba lmce  associated with space f l i g h t  i s  j u s t  now 
being considered i n  depth. Although it i s  not bel ieved t h a t  the  changes 
observed cons t i tu te  any immediate danger t o  the  crewmen, it i s  thought 
t h a t  t h i s  adaptation t o  a weightless s t a t e  cos ts  energy and uses reserves ,  
a s i t ua t ion  t h a t  places homeostatic mechanisms at the  edge of the  sa fe ty  
margin; furthermore, a severe s t r e s s  beyond t h i s  weightless s t a t e  would 
prove a d i f f i c u l t  challenge f o r  these  cont ro l  mechanisms. 
. 
The second area  of endocrine inves t iga t ion  ( t h e  quant i f ica t ion  of 
s t r e s s )  has been equally productive. 
a c t i v i t y  has provided assessment of each crewman's response t o  the  space- 
f l i g h t  environment. However, more data are needed f o r  a predict ion of 
pos t f l i gh t  response on the  basis  of p re f l igh t  values; and, only when 
samples a re  taken during the  f l i g h t ,  w i l l  t h i s  cor re la t ion  be complete. 
These examinations w i l l  not be possible until the  ear th-orb i ta l  Skylab 
missions, cur ren t ly  scheduled f o r  1973. Unt i l  t h a t  t ime, the  pieces  of 
t h i s  puzzle w i l l  be f i t t e d  together  t o  y i e l d  immediate understanding as 
w e l l  as t o  ensure a l l  necessary parameters w i l l  be considered during the  
i n f l i g h t  Skylab experiment. 
The measurement of adrenal hormone 
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TABU 3-1.- ADRENOCORTICOTROPHIC-HORMONE 
CONCENTRATIONS - APOLLO 8 MISSION 
[Normal range i s  10 t o  40 pg/ml] 
Subject 
Commander 
Command module 
p i l o t  
Lunar module 
p i l o t  
C on t r ol 
Concentration, pg/ml, a t  - 
14 days 
pref l igh t  
38 
22 
30 
25 
5 days 
p re f l igh t  
35 
40 
27 
35 
A s  soon as 
possible  
p o s t f l i g h t  
27 
30 
18 
20 
6 days 
post f l i g h t  
22 
25 
33 
22 
3-9 
Apollo 
mission 
TABLE 3-11.- BLOOD-SAMPLE-COLLECTION TIMES 
8 
9 
10 
11 
I2 
13 
Pre f l igh t  
Kennedy Space Center) 
co l lec t ion  period, 
e.s . t . ,  hr:min 
Immediately p o s t f l i g h t  
(recovery sh ip )  
co l lec t ion  period, 
e . s . t . ,  hr:min 
7:30 t o  8:30 a.m.  
7:30 t o  8:30 a.m. 
7:30 t o  8:30 a.m. 
7:30 t o  8 : 3 0  a.m. 
7:30 t o  8:30 a.m.  
7 : 3 0  t o  8 :30  a.m.  
12:OO p.m. 
1:30 p.m. 
2:OO p.m. 
2:OO p.m. 
5 : O O  p.m. 
3 : O O  p .m.  
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Figure 3-1.- Biochemical data -Project Mercury. 
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Figure 3-2.- Biochemical data - 
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4. REVIEW OF METABOLIC AND ENDOCRINE STUDIES 
ON THE GEMINI  V I 1  MISSION 
By Harry S. Lipscomb, M.D. , F.A.C.P." 
INTRODUCTION 
As the  Apollo Program moves i n t o  the f i n a l  phases and preparat ion 
is  made f o r  long-term, ear th-orb i ta l  missions, it may be worthwhile t o  
review some of t h e  earlier s tudies  derived from the  Gemini Program. It 
w a s  t he  author 's  good fortune t o  be involved i n  the  metabolic s tud ie s  
of a number of the Gemini f l i g h t s .  The 1 4 - d ~  Gemini V I 1  ea r th-orb i ta l  
mission w a s  t he  most completely documented ( r e f .  4-1). 
This unique study was planned within the  rigorous cons t ra in ts  of 
the technica l  cha rac t e r i s t i c s  of the  mission i t s e l f .  For t h i s  reason, 
it w a s  a formidable research task  t o  ensure tha t  adequate co l l ec t ion  of 
samples was obtained and t h a t  adequate p re f l igh t  and pos t f l i gh t  followup 
s tud ie s  were conducted properly.  
The primary goal of these  s tud ies  w a s  t o  measure changes, i f  any, 
t h a t  may have been produced by the  period of zero gravi ty  i n  space on 
t o t a l  body metabolism r e l a t e d  both '  t o  the  musculoskeletal and endocrine 
systems. The c r u c i a l  po in t  i n  the v a l i d i t y  of the da ta  derived from t h e  
Gemini V I 1  mission w a s  the  necessi ty  t o  have cor rec t  i n f l i g h t  urinary- 
excret ion volumes. Unaltered 24-hour r ena l  clearance and ur inary excre- 
t i o n  of c rea t in ine  had t o  be assumed. It w a s  necessary t o  ascr ibe the  
low and variable  ur inary c rea t in ine  values t o  the known incomplete and 
var iab le  ur ine  co l lec t ions  i n  f l i g h t .  It was impossible t o  ascr ibe t h i s  
lower ur inary c rea t in ine  value i n  f l i g h t  t o  muscle wastage because, when 
subjec ts  undergo severa l  weeks of extreme immobilization and bedrest  i n  
cas t s ,  t h e i r  ur inary c rea t in ine  has not declined. The f indings of the 
Gemini V I 1  mission are divided i n t o  severa l  sec t ions .  
*Professor of Physiology; Director ,  Xerox Health Care I n s t i t u t e ,  
Baylor College of Medicine, Houston, Texas 77025. 
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DISCUSSION 
Calcium Metabolism 
Increases of 23 and 9 percent were observed, respec t ive ly ,  i n  mean 
urinary calcium excretion i n  t h e  two crewmen. 
e a r l i e r  t h a t  immobilization by disease o r  i n  experimental s tud ie s  leads  
t o  increased bone resorp t ion  leading t o  hy-percalciuria and eventual 
osteoporosis. These e a r l i e r  bedrest  s tud ie s  c l e a r l y  showed a much more 
s t r i k i n g  hyperca lc iur ia  than t h a t  observed i n  t h e  Gemini V I 1  crewmen. 
It has been described 
The somewhat lower l e v e l s  of hyperca lc iur ia  i n  manned space f l i g h t ,  
as contrasted with those seen experimentally i n  bedrest  s tud ie s ,  were 
ind ica t ive  of s eve ra l  p o s s i b i l i t i e s .  
t he  bungee and o ther  moderate physical  a c t i v i t y  of t h e  mission i tself  
could have accounted f o r  the somewhat lower l e v e l s  of calcium excretion. 
The gaseous atmosphere of t h e  spacecraft  (100 percent oxygen a t  260 t o r r )  
has been shown t o  increase bone resorp t ion  i n  t h e  experimental environ- 
ment, and it w a s  believed tha t  hy-peroxia might contribute f'urther t o  
lo s ses  of calcium. Conversely, high a l t i t u d e  has been demonstrated t o  
decrease or suppress lo s ses  of calcium during bedres t .  
F i r s t ,  it w a s  evident tha t  use of 
It i s  of i n t e r e s t  t h a t  t h e  urinary excretion of calcium did  not 
change s i g n i f i c a n t l y  during the f irst  7 days of space f l i g h t  i n  e i t h e r  
crewman; but ,  s t a r t i n g  on the eighth day, a d e f i n i t e  increase occurred 
f o r  t h e  command p i l o t  and pe r s i s t ed  during t h e  4 days of p o s t f l i g h t  ob- 
se rva t ion .  Dermal lo s ses  of calcium were low f o r  both crewmen during 
f l i g h t .  
Phosphate 
A s i g n i f i c a n t  increase i n  urinary phosphate excretion was noted 
over the f irst  9 daJrs of space f l igh t .  
constant d i e t a ry  in take ,  urinary excretion of phosphate dropped t o  near 
cont ro l  levels. 
Thereafter, desp i te  r e l a t i v e l y  
Sulfate 
Urinary s u l f a t e  excretion d id  not change s i g n i f i c a n t l y  during space 
Sul fa te  excretion data tend t o  resemble those of nitrogen. f l i g h t .  
Nitrogen 
Urinary nitrogen decreased i n  both crewmen during f l i g h t  and re- 
turned t o  p re f l igh t  values during t h e  p o s t f l i g h t  phase. Dietary nitrogen 
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in take  was s i g n i f i c a n t l y  less during t h e  f l i g h t ,  with t h e  r e s u l t  t h a t  
nitrogen balance became negative during the  f l i g h t  phase. 
Magnesium 
Urinary excre t ion  of magnesium did  not change during the f irst  week 
of space f l i g h t ;  bu t ,  i n  t he  command p i l o t ,  s i g n i f i c a n t l y  increased 
amounts of magnesium were excreted i n  the second week, as noted f o r  
calcium excretion. 
4 days of p o s t f l i g h t  study, urinary magnesium excretion decreased dra- 
matically.  The c o p i l o t ' s  pa t t e rn  w a s  similar but changes were not 
s ign i f i can t  . 
Toward t h e  end of the mission and p e r s i s t i n g  through 
Pot ass i u m  
Potassium excretion var ied  s t r i k i n g l y  between t h e  two crewmen. The 
command p i l o t  showed an i n i t i a l  decrease i n  urinary potassium i n  f l i g h t  
i n  the  presence of a marked decrease i n  d i e t a ry  potassium. 
second week of f l i g h t ,  urinary potassium rose ;  bu t ,  immediately a f t e r  t h e  
f l i g h t ,  potassium excretion f e l l  t o  p re f l igh t  values as t h e  d i e t a ry  in- 
take w a s  increased. On the o ther  hand, the copilot  demonstrated only a 
s l i g h t  decrease i n  urinary potassium i n  t h e  first week of f l i g h t  desp i te  
a marked r e s t r i c t i o n  i n  in take .  During the second week, excretion de- 
creased f u r t h e r  and rose t o  p r e f l i g h t  values during the recovery phase. 
During the 
Sodium and Chloride 
Again, d i f f e r e n t  pa t t e rns  were observed between t h e  crewmen. Despite 
a s l i g h t  decrease i n  d i e t a ry  sodium, t h e  command p i l o t  experienced in- 
creased sodium excretion during t h e  f irst  week of f l i g h t ,  a r e tu rn  t o  
cont ro l  values during the  second week, and s ign i f i can t  r e t en t ion  i n  the 
ea r ly  p o s t f l i g h t  period. Conversely, t he  copi lo t  demonstrated no change 
i n  sodium excretion during the f irst  p a r t  of the f l i g h t ,  an increase 
t h e r e a f t e r ,  but then, similar t o  t h e  command p i l o t ,  marked r e t e n t i o n  i n  
the p o s t f l i g h t  period. 
Hormone Excretion 
I n  the  cop i lo t ,  epinephrine excretion and, more var iab ly ,  norepine- 
phrine excretion were greatest on t h e  2 days of t h e  g rea t e s t  p red ic ted  
stress - t h e  day of l i f t - o f f  and t h e  day of splashdown. The command 
p i l o t  catecholamine excretion approximated t h i s  p a t t e r n ,  but the values 
were not s i g n i f i c a n t l y  d i f f e r e n t  from t he  con t ro l ,  p r e f l i g h t  phase. 
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Excretion of 1~-hydroxycorticosteroids w a s  low i n  both crewmen 
throughout t h e  e n t i r e  f l i g h t .  I n  both sub jec t s ,  t h i s  measurement was 
elevated only on the  day of splashdown. The few values f o r  urinary 
aldosterone obtained were elevated during and immediately a f t e r  t h e  
f l i g h t .  
CONCLUSIONS 
I n  view of t h e  numerous influences i n  space f l i g h t  -notably 
100-percent-oxygen atmosphere, one-third atmospheric pressure,  and 
r e l a t i v e l y  uncontrolled but s t r i k i n g l y  l imi t ed  physical a c t i v i t y  , i n  
addition t o  weightlessness - t h e  metabolic e f f e c t s  of manned space 
f l i g h t  i n  the  weightless condition, as such, were not determined defin- 
i t i v e l y .  The various metabolic changes observed represent t h e  ne t  e f f e c t  
of severa l  d i f f e r e n t  (both concurrent and counteracting) f ac to r s  , pre- 
dominantly physical i n  nature.  
t h i s  f irst  metabolic study i n  space, changes i n  mineral and hormonal 
balance w e r e  s u f f i c i e n t l y  modest t o  support , from t h e  metabolic point 
of view, the  decisions t h a t  a voyage t o  and re turn  from the  moon would 
be medically sa fe ,  because the  time required would be no more and, i n  
f a c t ,  less than the  duration of t h e  Gemini V I 1  mission. I n  much longer 
missions, however, t he  necess i ty  f o r  addi t iona l  metabolic observations 
i s  evident. 
Within t h e  broad l i m i t s  of p rec is ion  of 
I n  p a r t i c u l a r ,  it i s  believed t h a t  most ca re fu l  sc ru t iny  must be given 
t o  the  ins i s tence  on exercise on a regular  basis as an i n t e g r a l  p a r t  o f  
space f l i g h t  t o  prevent predicted calcium losses  i n  ur ine  and the sub- 
sequent destruction of bone. Equally important, t he  changes observed i n  
red-blood-cell mass (described by other conference a t tendees)  - most 
reasonably associated with the  atmospheric conditions of f l i g h t  - and 
t h e  changes i n  blood-pressure maintenance and regulation w i l l  require 
most scrupulous a t t en t ion .  F ina l ly ,  ea r ly  highly suggestive evidence 
e x i s t s  t o  support t he  contention t h a t  glomerular f i l t r a t i o n  and r e n a l  
function (as it r e l a t e s  t o  aldosterone and s t e r o i d  sec re t ion )  requi res  
more ca re fu l  study. 
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5. JOINT AMES RESEARCH CENTER/MA"ED SPACECRAFT CENTER STUDY: 
DIURNAL VARIATION I N  ADRENOCORTICAL 
AND THYROID FUNCTION DURING PROLONGED BEDREST 
By Joan Vernikos-Danellis, Ph. D.* 
INTRODUCTION 
A t  t h e  NASA Ames Research Center, t he  emphasis i n  t h e  endocrine 
research program t h a t  w i l l  be discussed has been mostly on t h e  f a c t o r s  
a f f ec t ing  t h e  endocrine system, p a r t i c u l a r l y  t h e  hypothalamic-pituitary- 
adrenal system and t h e  stress response. The program has involved such 
various aspects as t h e  study of t h e  mechanisms mediating t h e  secre t ion  
of cor t ico t ropin- re leas ing  hormone and adrenocorticotrophic hormone 
(ACTH) , feedback mechanisms , c e n t r a l  and per iphera l  autonomic mechanisms, 
drugs, psychological and environmental var iab les  t h a t  a f f e c t  t h e  s t r e s s  
response, and t h e  development of methods f o r  t h e  bioassay of t hese  hor- 
mones i n  blood and o ther  t issues.  Most of t h i s  work has been done i n  
animals, primarily t h e  rat ,  and t o  a smaller extent i n  man. 
More d i r e c t l y  space-related work has involved e n t i r e l y  t h e  use of 
simulation of weightlessness by bedrest i n  man o r  ex t rapola t ion  by ex- 
pos.ure of rats t o  increased g-loads by chronic cent r i fuga t ion  and 
comparison with exposure t o  o ther  chronic s t r e s s  s t imu l i .  
What has become evident  from t h e  chronic  s t u d i e s  i n  rats has been 
t h e  t r a n s i e n t  o r  lack of apparent changes i n  "basal" l e v e l s  of ACTH o r  
co r t i cos t e ro ids  ( i f  sampled at a s ing le  point d a i l y ) ,  although very 
marked e f f e c t s  were evident i n  t h e  magnitude and d i r ec t ion  o f  t h e  
response t o  an add i t iona l  acute standardized stimulus (such as 1 minute 
e t h e r ) ,  and these  e f f e c t s  were dependent on t h e  duration and i n t e n s i t y  
of exposure. It has been my contention, t he re fo re ,  t h a t ,  t o  assess t h e  
a b i l i t y  of t h e  p i tu i ta ry-adrena l  system not only t o  maintain normal 
physiological function but a lso t o  respond t o  an added unexpected 
challenge at various poin ts  during chronic exposure t o  some a l t e r a t i o n  
i n  t h e  environment, it may be desirable ( i n  addition t o  estimating basal 
l e v e l s )  t o  impose t e s t s  of s p e c i f i c  endocrine organ function. 
*Research S c i e n t i s t ,  Ames Research Center, Moffett F i e ld ,  Cal i forn ia  
94035. 
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DISCUSS I ON 
In  an e f fo r t  t o  c o l l e c t  preliminary information about changes i n  
the  endocrine system of man during prolonged exposure t o  hypokinesic 
conditions and t o  pos tura l  changes and confinement, c o r t i s o l ,  thyroxine,  
and tri- iodothyronine blood leve ls  were determined during a 56-day 
bedrest  study t h a t  w a s  performed under contract  by t h e  Manned Spacecraft 
Center. 
The circadian rhythm of the  plasma adrenocort ical  hormone l eve l s  i n  
humans has been described by severa l  inves t iga tors  and appears t o  be 
wel l  es tabl ished.  
var ia t ion  i n  thyroid a c t i v i t y  has been inves t iga ted  using only ind i r ec t  
indices without d e f i n i t e  conclusions being achieved. For instance,  
f luc tua t ions  i n  protein-bound iodine have been reported t o  run p a r a l l e l  
t o  adrenal a c t i v i t y ,  whereas the  iodine-131 uptake of t h e  thyroid gland 
shows t h e  opposite pa t t e rn  with t h e  peak between 7:30 and 11:30 p.m. 
( r e f .  5-11, 
On t h e  other  hand, t he  p o s s i b i l i t y  of a d iurna l  
Past  bedrest  s tud ies  i n  healthy human subjects  have generally 
ignored any changes i n  the  endocrine system with t h e  exception of 
sporadic da i ly  or even weekly ur inary steroid-excretion measurements. 
Onlx t h e  1965 study of Cardus e t  a l .  (ref.  5-21, measuring t h e  circadian 
rhythm of plasma l eve l s  of 1~-hydroxycorticosteroids, repor t s  no s i g n i f i -  
cant changes a f t e r  3 days of bedrest .  
Eight heal thy males, aged 20 t o  40, were submitted t o  bedrest  f o r  
56 days on a 14-hour-light , 10-hour-dark regimen (lights on at 9 : O O  a.m. 
and fed  an Apollo d i e t .  Four of t hese  subjec ts  exercised with an 
Exer-Genie th ree  times da i ly  throughout t h e  experiment. Blood samples 
were drawn by r e p e t i t i v e  venous punctures at hourly in t e rva l s  f o r  48-hour 
periods before bedres t ,  at 10, 20, 30, 42, and 54 days a f t e r  confinement 
t o  bed, and 10 days a f t e r  t h e  subjec ts  had again been ambulatory. 
Plasma-free c o r t i s o l  l eve l s  were determined by Murphy's competitive 
protein-binding radioassay and expressed as vg/lOO m l  plasma. 
t o t a l  thyroxine w a s  expressed as pg/lOO ml serum, and serum tri- 
iodothyronine was estimated by determining t h e  binding capaci ty  of 
serum t o  t h e  hormone and expressed as r e l a t i v e  percent uptake. 
Serum 
The re la t ionship  of t h e  rhythm i n  c i r cu la t ing  l e v e l s  of hydrocorti- 
sone, thyroxine,  and tri- iodothyronine i n  t h e  e ight  subjects  during t h e i r  
ambulatory prebedrest  control  period is  shown i n  f igu re  5-1. A l l  t h r ee  
hormones showed a s ign i f i can t  d iurna l  f luc tua t ion  with m a x i m a l  l eve l s  
occurring at 7:30 a . m . ,  an t ic ipa t ing  l i g h t s  on. I n  addi t ion ,  thyroxine 
showed a secondary peak a t  3:30 p.m. 
hormone rhythms w a s  much smaller than t h a t  of t he  cor t icos te ro id .  
The amplitude of both thyroid- 
5-3 
The plasma hydrocortisone rhythm at various in t e rva l s  during t h e  
study i n  t h e  four subjects  t h a t  exercised and t h e  four t h a t  d id  not i s  
shown i n  f igure  5-2. Bedrest had l i t t l e  e f f e c t  on t h e  circadian 
rhythmicity of t h i s  hormone. A s ign i f i can t  f luc tua t ion  i n  plasma cor- 
t i s o l  was evident with peak l eve l s  occurring around 7 : 3 0  a . m .  throughout 
t h e  experiment. However, progressive bedrest  reduced t h e  amplitude of 
t h e  s t e r o i d  rhythm and ne i ther  exercise  nor t h e  10-day postbedrest  
ambulatory period prevented o r  corrected t h i s  reduction i n  amplitude. 
The occurrence of t h e  peak i n  plasma c o r t i s o l  w a s  more var iab le  i n  t h e  
exercised subjects .  
The use of t h e  summation d i a l  t o  depict  these  r e s u l t s  i s  i l l u s t r a t e d  
i n  f igure  5-3. The summation-dial method' of describing nonstationary 
b io logica l  t i m e  series da ta  w a s  developed at t h e  Ames Research Center 
by Hetherington, Rosenblatt ,  and Winget and emerged of necessi ty  as a 
r e s u l t  of t h i s  bedrest study. Br ie f ly ,  t h e  curve best f i t t e d  the  da ta  
i s  derived mathematically assuming a spec i f ied  period (e.g. , 
Each point  on t h e  curve represents  the end of a vector w i t h  a ce r t a in  
magnitude and d i rec t ion  describing t h e  phase of t h e  rhythm f o r  t h a t  day. 
The summation of these  vectors or  t r a i n  of vectors produces t h e  summa- 
t i o n  d i a l .  The d i rec t ion  of the  vector t r a i n  i s  t h e  hour of t h e  day at 
which estimated peak a c t i v i t y  occurred. The length of t he  vector  indi-  
cates  the  amplitude of the rhythm. I n  t h i s  instance,  it i s  shown t h a t  
t h e  exercised group of subjects  peaked about 1 hour before t h e  
nonexercised. 
T = 24 h r ) .  
In  cont ras t  t o  the remarkable s t a b i l i t y  of t h e  plasma hydrocorti- 
sone rhythm, both thyroid hQrmones showed very unstable rhythms during 
the bedrest  period w i t h  a re turn  t o  o r ig ina l  rhythmicity at t h e  post- 
bedrest  co l lec t ion  period. This i n s t a b i l i t y  of t he  thyroxine rhythm 
i s  shown i n  f igure  5-4; that  of t h e  tr i- iodothyronine rhythm, i n  
f igure  5-5. 
rhythms. 
Exercise did not appear t o  increase t h e  s t a b i l i t y  of these  
Correlations over time between physiological parameters may be 
s tudied  by use of t h e  vector-difference d i a l  t h a t  quant i f ies  t he  angle 
between t h e  summation d i a l s  of these two parameters. Comparison of 
c o r t i s o l  with tr i- iodothyronine rhythms i n  nonexercised subjects  
( f i g .  5-6) throughout t he  study shows per fec t  cor re la t ion  i n  the  occur- 
rence of t h e  t i m e  of peak of t h e  two rhythms f o r  the  prebedrest  period 
and t h e  first pa r t  of t h e  study. 
day of bedrest  with t h e  r e s u l t  t ha t  the hydrocortisone peak l e d  t h e  
tr i- iodothyronine by 6 hours. 
t h e  42nd day with the  peak i n  tr i- iodothyronine occurring 12 hours 
before t h a t  of plasma hydrocortisone. 
bedrest  per iod,  the thyro id  and hydrocortisone rhythms again showed 
per fec t  cor re la t ion .  
A rephasing occurred about the  20th 
Additional rephasing occurred at about 
However, 10 days after t h e  
5-4 
To i l l u s t r a t e  t h e  e f f e c t  of continuous bedrest  and of exercise  on 
the  mean c i rcu la t ing  l eve l s  of these  three  hormones, t he  results are  
expressed somewhat d i f f e ren t ly  i n  the f i n a l  th ree  figures. 
The mean plasma c o r t i s o l  per  48-hour sampling period ( s o l i d  l i n e )  
i n  the  exercised and nonexercised subjects  i s  shown i n  f igure  5-7. The 
c i r c l e s  and connecting dashed l i n e s  i n  t h i s  and t h e  next two f igures  
represent t he  mean maximal and minimal concentrations ( o r  amplitudes ) 
t h a t  occurred during t h a t  period, i r respec t ive  of t h e  hour of day t h a t  
they occurred. In  t h e  nonexercised subjec ts ,  t h e  results show a reduc- 
t i o n  i n  t h e  mean da i ly  c o r t i s o l  l e v e l  ahd a marked reduction i n  t h e  
da i ly  range. 
da i ly  output and i n  the  da i ly  range between t h e  10th and 14th day of 
bedrest ,  but t h i s  r i s e  w a s  not maintained and a reduction i n  amplitude 
followed as i n  t h e  nonexercised subjects .  It i s  important t o  note tha t  
t he  amplitude i s  s t i l l  reduced a t  t h e  end of t h e  10-day postbedrest 
ambulatory ac t iv i ty .  
The exercised subjects  showed a t r ans i en t  rise i n  t h e  mean 
I n  a similar fashion, t he  changes i n  c i r cu la t ing  thyroxine are 
shown i n  f igure 5-8. Both exercised and nonexercised subjects  show 
s i m i l a r  pa t te rns .  The only e f f e c t  of bedrest  appeared t o  be a t r ans i en t  
increase i n  t h e  mean da i ly  concentration during t h e  first 10 days with 
no change i n  amplitude throughout t h e  experiment. However, i n  both 
groups of subjec ts ,  a dramatic increase i n  mean thyroxine l eve l s  w a s  
noted when t h e  subjects  got out of bed. 
On t h e  other  hand, as shown i n  f igure  5-9, t h e  concentration of tri- 
iodothyronine markedly increased during the  f irst  f e w  days of t h e  study 
and remained elevated i n  both groups of subjec ts  f o r  t h e  duration of 
t h e  experiment as wel l  as through the  postbedrest  period. 
CONCLUDING REMARKS 
The da ta  ind ica te  t h a t  a l t e r i n g  the  hydrostat ic  pressure f o r  long 
periods of time causes a reduction i n  t h e  c i r cu la t ing  hydrocortisone 
rhythm amplitude, increases  i n  thyroid hormone l eve l s  (desp i te  t he  ex- 
pected reduction i n  metabolic rate),  and a desynchronization of thyroid 
rhythms with l ight  as w e l l  as s te ro ids .  
s t e ro ids  has been described as being associated with s leep  r a the r  than 
with the l i g h t  schedule. The d issoc ia t ion  of the thyroid rhythms from 
both t h e  hydrocortisone rhythm and the l ight-and-activity schedule, 
and t h e  prompt reassociat ion of the  two rhythms i n  t h e  postbedrest  
ambulatory period suggest t h a t  the thyroid rhythm may be posture 
dependent. 
The d iurna l  rhythm i n  plasma . 
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Exercise has been used o r  at l e a s t  suggested as t h e  prophylact ic  o r  
This correct ive e f f e c t  was ce r t a in ly  
correct ive measure f o r  cardiovascular and metabolic changes occurring 
during bedrest  and weightlessness.  
not evident i n  t h i s  study i n  which ne i ther  a vigorous exerc ise  program 
nor t h e  l 0 - d v  postbedrest  ambulatory period prevented o r  corrected t h e  
hea r t  r a t e ,  temperature, and endocrine changes induced by 56 days of 
absolute bedrest .  It would appear from these  data t h a t  cor rec t ive  
measures o ther  than exercise  should be sought. 
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Figure 5-1.- Diurnal rhythms i n  mean c i r c u l a t i n g  c o r t i s o l ,  thyroxine, and 
tri- iodothyronine i n  e ight  normal ambulatory subjec ts .  Ver t i ca l  l i n e s  
represent standard e r r o r  of the mean; s t i pp led  a reas  represent  l i g h t s -  
o f f  periods . - .  
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Figure 5-2.- Plasma c o r t i s o l  rhythm i n  four exercised and 
four nonexercised subjec ts  before ,  during, and a f t e r  56 days 
of bedrest .  St ippled areas  represent  l ights-off  periods.  
16:30 17:30 18:30 19:30 20:30 21:30 22:30 
15: 30 
14: 30 
13: 30 
12: 30 
11: 30 
10: 30 
09: 30 
I I ;  \ 
23: 30 
00:m 
01: 30 
02: 30 
03: 30 
04: 30 
05: 30 
08: 30 07: 30 06: 30 
Ti me, h r: mi n 
Figure 5-3.- Summation dial of plasma cortisol 
rhythm in four exercised and four nonexercised 
subjects during 56 days of bedrest. 
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Figure 5-4.- Serum tri-iodothyronine i n  four exercised and four  
nonexercised subjec ts  before ,  during, and a f t e r  56 days of 
bedrest .  Stippled areas represent l igh ts -of f  periods.  
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Figure 5-5.- Serum thyroxine in four exercised and four non- 
exercised subjects before, during, and after 56 deys of 
bedrest. Stippled areas represent lights-off periods. 
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Figure 5-7.- Mean c i r cu la t ing  c o r t i s o l  ( s o l i d  l i n e )  per  48-hour sampling 
period i n  four  exercised and four nonexercised subjects .  Open c i r c l e s  
and dashed l i n e s  represent the mean maximal and min ima l  concentrations 
f o r  that period i r r e spec t ive  of the hour of the day that they occurred. 
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Figure 5-8.- Mean c i r cu la t ing  thyroxine ( s o l i d  l i n e )  per &hour sampling 
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and dashed l i n e s  represent  t he  mean maximal and minimal concentrations 
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c i r c l e s  and dashed l i n e s  represent t h e  mean maximal and miniplal concen- 
t r a t i o n s  f o r  t h a t  period i r respec t ive  of t h e  hour of t h e  day t h a t  they 
occurred. 
r Nonexercised 
D-..Q--- -o-- co - 1 4 -p&H- 
0 
-0 4’’ - 
0 
0 
0 
~ 
I I I I I I 
. 
6-1 
6. RADIOIMMUNOASSAY OF ANTIDIURETIC HORMONE 
by Wron Mil ler ,  M.D.* 
Many problems i n  the adaption of man t o  space appear t o  be r e l a t e d  
The work on the  development of 
t o  changes i n  plasma volume and i n  total-body-water regulat ion,  with many 
other  changes taking place secondarily. 
a radioimmunoassay system f o r  urinary an t id iu re t i c  hormone (ADH) w i l l  be 
discussed i n  t h i s  sect ion.  (The appl icat ion of t h i s  system t o  the  meas- 
urement of ur inary ADH i n  the  study of man i n  space i s  presented i n  
sect ion 3 . )  The da ta  t o  be shown w i l l  highl ight  some of the  features of 
t he  assay and some of t h e  evidence tha t  demonstrates t h a t  changes i n  
urinary ADH excret ion occurs a f t e r  physiological s t imulat ion and t h a t  
these changes can be measured. 
The assay system uses an antibody t h a t  w a s  developed by immunizing 
r abb i t s  with lys ine  vasopressin (LVP),  which i s  one amino ac id  d i f f e ren t  
from arginine vasopressin (AVP) , the  na tu ra l  ADH of man. The LVP was 
coupled t o  bovine serum albumin using the  carbodiimide condensation re- 
act ion.  The antibody obtained reacted not only with t h e  o r ig ina l  an t i -  
gen, LVP, but a l s o  cross-reacted with AVP. Assays were performed using 
1251-labeled LVP as the  antibody and synthet ic  AVP as the  standard. 
a ra t ion  of antibody bound from f r ee  
using the  double-antibody-precipitation procedure ( f i g .  6-1). 
l i m i t  of s e n s i t i v i t y  i s  approximately 25 pU AVP/ml and a dose-response 
curve occurs from 25 t o  10 000 pU AVP/ml.  The lower l i m i t  of s e n s i t i v i t y  
is  equivalent t o  62 pg AVP/ml. Greater s e n s i t i v i t y  w a s  noted when LVP 
w a s  used i n  place of AVP as the  standard.  
Sep- 
w a s  o r ig ina l ly  performed 
The lower 
Present ly ,  albumin-coated charcoal i s  used t o  separate  antibody 
bound frm free L v P - ~ ~ ~ I  ( f i g .  6-2). 
dose-response curve very s i m i l a r  t o  t h e  curve obtained with the  double- 
antibody procedure. The charcoal method has many advantages i n  that  it 
allows t h e  assays t o  be performed over a shor te r  period of t i m e ,  a t  les -  
ser cos t ,  and with decreased v a r i a b i l i t y .  
some an t i s e ra ,  s e n s i t i v i t y  t o  a l e v e l  of 10 pU/ml  i s  achieved occasionally.  
This charcoal method produces a 
On some occasions and with 
*Veterans Administration Hospital;  a l so  Department of Medicine, 
S t a t e  University of New York, Upstate Medical Center, Syracuse, New 
York 13210. 
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The antibody produced is  capable of cross-reacting w i t h  a var ie ty  
of neurohypophyseal peptides ( f i g .  6-3). 
immunize the animals, exhib i t s  t he  greatest s e n s i t i v i t y  w i t h  approxi- 
mately a twofold increase i n  s e n s i t i v i t y  over AVP. Phenylalanine-2 LW, 
which d i f f e r s  from the  LVP only i n  the subs t i tu t ion  of a phyenylalanine 
i n  posi t ion 2, a l so  cross-reacts i n  the  system. Oxytocin has no cross- 
r e a c t i v i t y  i n  t h i s  assay. 
The LW, the material used t o  
The next s e r i e s  of s tud ies  concerns some of the b io logica l  work per- 
formed t o  va l ida te  the  methodology. 
ta ined from rats t h a t  had been subjected t o  varying degrees of dehydration 
so tha t  the content of ADH i n  the pos te r ior  lobe varied considerably. 
These p i t u i t a r i e s  were assayed simultaneously using t h e  immunoassay and 
a standard pressor-bioassay procedure ( f i g .  6-41, The regression l i n e ,  
obtained by p lo t t i ng  values determined by immunoassay against  those 
determined by bioassay, i l l u s t r a t e s  that  excel lent  agreement ex i s t s  be- 
tween the  two assay methods. I n  general ,  t he  immunoassay r e s u l t s  i n  
values t h a t  a re  s l i g h t l y  higher than those of t he  bioassay l eve l s .  
Pos te r ior  p i t u i t a r y  glands were ob- 
A pool of plasma from normal human subjects  was obtained and graded 
amounts of AVP were added t o  a l iquots  of the  plasma. The plasmas were 
then extracted and assayed using both the immunoassay system and t h e  
an t id iu re t i c  bioassay system ( f i g .  6-5). 
the microunit range, good agreement again e x i s t s  between t h e  values 
obtained using the immunoassay and the  bioassay procedures. 
munoassay values a re  s l i g h t l y  higher than t h e  bioassay values. Plasma 
samples, t o  which no ADH had been added, contained approximately 5 VU AW/ 
m l  of plasma (as determined by b iaassay) ,  and the  same samples contained 
from 5 t o  25 pU AVP/ml of plasma (as determined by immunoassay). This 
d i spa r i ty  i n  values ind ica tes  the detect ion by t h e  immunoassay of some 
component t h a t  w a s  not detectable  i n  the bioassay system. This component 
may represent the presence of p a r t i a l l y  degraded forms of vasopressin 
that  a re  no longer b io logica l ly  ac t ive  but  t h a t  r e t a i n  immunoreactivity. 
Other da ta  ind ica te  t h a t  t he  b io logica l  a c t i v i t y  of vasopressin can be 
a l t e r ed  while the immunological a c t i v i t y  i s  s t i l l  re ta ined.  The d i su l f ide  
l ink i n  vasopressin can be broken without a f f ec t ing  the immunological 
a c t i v i t y  of the vasopressin,  whereas such a break w i l l  destroy most of 
the  b io logica l  a c t i v i t y  of ADH. Other changes t h a t  w i l l  decrease the 
b io logica l  a c t i v i t y  can be made i n  the  molecule, but the changes have a 
lesser e f f ec t  on the  immunological a c t i v i t y .  Thus, it i s  not d i f f i c u l t  
t o  obtain disassociat ion between the two a c t i v i t i e s .  
I n  these assays,  which are i n  
The im-  
I Urine specimens were obtained from rats that were normal o r  that  had 
varying degrees of diabetes insipidus ( f i g .  6-6). A f t e r  ex t rac t ion  of 
the ADH, t he  samples were assayed simultaneously using the  immunoassay 
and the  an t id iu re t i c  bioassay. Again, excel lent  agreement occurred be- 
tween the  two assay procedures. The immunoassay revealed a small amount 
of a c t i v i t y  t h a t  w a s  not detected by the  bioassay. 
L 
I ’  
The lower l i m i t  of s e n s i t i v i t y  of t h e  immunoassay i s  approximately 
25 VU AVP/ml. Therefore, ex t r ac t ion  and concentration of these  f l u i d s  
were required t o  obtain a r e l i a b l e  measurement of t he  amount of ADH i n  
b io log ica l  f l u i d s .  
and then passed through a column of the  ion-exchange-resin CG-50. The 
ADH i s  adsorbed by the  r e s i n  while the  ur ine  passes through. 
were then washed once with water and again with 50 percent alcohol (both 
of these  so lu t ions  were a t  a pH of 4 . 5 ) .  
of salts  and o ther  small peptides,  and ADH remains on t h e  column. When 
75 percent alcohol,  a t  a pH of 2 ,  i s  passed through t h e  column, ADH i s  
quan t i t a t ive ly  removed and the  e lua t e  i s  then evaporated and s to red  f o r  
l a t e r  assay. 
Urine w a s  a c i d i f i e d  with a c e t i c  ac id  t o  a pH of 4.5 
The columns 
The wash results i n  the  removal 
The percent recovery achieved using t h i s  procedure i s  l i s t e d  i n  
t a b l e  6-1. When L v P - ~ ~ ~ I  w a s  used and t h e  r ad ioac t iv i ty  recovered at 
the  end of t he  ex t r ac t ive  procedure w a s  determined, 89.4 percent of t h e  
L v P - ~ ~ ~ I  applied t o  the  column was recovered. When known mounts of AVP 
were added t o  urine obtained from p a t i e n t s  with complete diabetes insip- 
idus and the  ur ine  was passed through the  columns and then assayed, t h e  
mean recovery rate was 98.5 percent.  
procedure i s  seve ra l  hours. Consequently, a specimen can be co l lec ted ,  
processed, evaporated, and s to red  i n  a s ingle  day. 
The time required f o r  t h e  ex t r ac t ive  
Biological experiments were performed using the  ur inary  extraction- 
and-concentration procedure and the  immunoassay method of measuring ADH. 
Urinary ADH excretion w a s  determined i n  Bratt leboro rats t h a t  were e i t h e r  
normal, had complete diabetes ins ip idus ,  or had a heterozygous form of 
diabetes ins ip idus  i n  which approximately one-half t he  normal amount of 
vasopressin i s  present i n  the  pos t e r io r  p i t u i t a r y  gland. The r e l a t ionsh ip  
observed between the  pos t e r io r  p i t u i t a r y  ADH content and ur inary  ADH 
excretion was exce l len t .  I n  normal animals, mean urinary ADH excretion 
w a s  4.6 mu AVP/day whereas, i n  t h e  animals with complete diabetes ins ip-  
idus,  only small amounts of immunoreactivity - equivalent t o  approxi- 
mately 100 pU of AVP/day ( f i g .  6-7) -were observed. The mater ia l  i n  
t he  animals with complete diabetes ins ip idus  i s  probably not AVP because 
t h e  material does not have b io log ica l  a c t i v i t y .  
heterozygous form of diabetes ins ip idus  (which have approximately one- 
ha l f  t h e  normal amount of ADH i n  the  pos t e r io r  p i t u i t a r y )  a l s o  excrete 
about one-half t h e  normal amount of ADH i n  the  ur ine  - 2.3 pU/day. 
f o r e ,  an exce l len t  co r re l a t ion  e x i s t s  between urinary ADH excretion and 
neurohypophyseal ADH content. 
The animals with the  
There- 
Close co r re l a t ion  a l s o  e x i s t s  between t h e  urinary ADH excretion and 
urine osmolali ty,  and between the  urinary ADH excretion and ur ine  volume 
( f i g .  6-8). I n  t h e  rats with diabetes ins ip idus  (which have l a rge  volumes 
of very d i l u t e  u r ine )  t he  r a t e  of ADH excretion i s  very low. Normal rats 
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(which have a ur ine  osmolality of approximately 2300 mOsm/kg) have a high 
rate of excretion of ADH and an inverse cor re la t ion .wi th  t h e  urine volume, 
as would be expected. 
I n  normal animals, i n  response t o  a 4-day period of dehydration, t he  
urinazy ADH excretion rises approximately f ive fo ld  from a base-line value 
of 3.6 t o  18.2 mU/day ( f i g .  6-9). When these  rats are subsequently given 
access t o  water, t he  urinary ADH values promptly f a l l  back t o  a l e v e l  
t h a t  i s  even lower than i n  the  basal state.  The animals evidently drink 
excessively i n  response t o  the  previous dehydration and, consequently, 
the  ADH-release mechanism i s  e f f ec t ive ly  inh ib i t ed .  I n  t h e  animals with 
t h e  heterozygous form of diabetes ins ip idus ,  t h e  same phenomenon occurs 
but t o  a l e s s e r  degree. 
and undergo a threefo ld  increase t o  5.6 mU/day i n  response t o  dehydration. 
After t he  rats have had access t o  water,  t h e  ADH excretion f a l l s  sharply 
t o  l e s s  than the  basal values. The animals with complete diabetes insip- 
idus do not increase the  excretion of ADH-like material i n  response t o  
dehydration and, when the  animals again a re  given access t o  water, t he  
immunoreactive material in the urine falls significantly, suggesting that 
t h e  material being measured i n  these  animals o r ig ina t e  i n  t h e  neuro- 
hypophyseal system. This reac t ion  may represent a precursor or abnormal 
peptide t h a t  does have some immunoreactivity i n  t h i s  system. 
These animals excrete approximately 2 mu AVP/day 
Same preliminary data have been obtained i n  humans ( f i g .  6-10). 
a group of 25 normal sub jec t s ,  u r ine  specimens were co l lec ted  every 
24 hours from indiv idua ls  while under conditions of normal a c t i v i t y ,  eat- 
ing ,  and drinking. The mean osmolality of these  urine specimens w a s  
940 mOsm/kg. 
I n  individuals who were given water loads so  t h a t  t h e i r  u r ine  osmolality 
f e l l  t o  a mean of 67 mOsm/kg, ADH disappeared e n t i r e l y  from t h e  ur ine .  
Two p a t i e n t s  with inappropriate ADH syndrome secondary t o  carcinoma of 
t h e  lung were a l so  s tudied .  
excre t ion ,  f a r  above t h a t  observed i n  normal ind iv idua ls .  The second 
pa t i en t  had a value i n  t h e  same range as normal subjec ts .  However, t he  
plasma osmolality i n  t he  second p a t i e n t  w a s  approximately 252 mOsm/kg - 
a value far below the  normal plasma osmolality of 285 t o  288 mOsm/kg. 
Thus, t he  ur ine  ADH value obtained w a s  inappropriately high. I n  th ree  
p a t i e n t s  with diabetes ins ip idus  who had a mean urine osmolality of 
90 mOsm/kg, no de tec tab le  ADH w a s  found i n  the  ur ine .  
I n  
The mean ADH excretion was 1.3 mU/hr over t h e  24-hour period. 
One p a t i e n t  had a markedly elevated ADH 
The response of a normal ind iv idua l  t o  an o r a l  water load i s  i l l u s -  
t r a t e d  i n  f igu re  6-11. 
ADH excretion w a s  2.8 m U / h r .  After administration of t h e  water load ,  a 
progressive decrease i n  urine osmolality from 950 mOsm/kg t o  70 mOsm/kg 
w a s  observed. Concurrently, diuresis began and ADH decreased, s o  t h a t ,  
at t he  end of an hour, ADH had disappeared from t h e  urine.  The water 
load w a s  maintained fo r  a period during which t h e  urine osmolality re- 
mained low and ADH w a s  absent. A s  t he  water load w a s  allowed t o  be 
After a period of 18 hours of dehydration, ur inary  
. 
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excreted and as the ur ine  osmolality began t o  r i s e  again,  ur ine volume 
f e l l ,  and ADH reappeared i n  the  ur ine.  
osmolali ty w a s  s t i l l  below the  l e v e l  of the  plasma osmolali ty.  
ADH release appeared t o  begin t o  occur when the  l e v e l  of ur ine osmolali ty 
reached approximately 125 mOsm/kg. 
The ADH reappeared when ur ine  
Thus, 
The same type of study was performed i n  a pa t i en t  with the  inappro- 
The pa t i en t ,  who had previously been water r e s t r i c t e d ,  w a s  
p r i a t e  ADH syndrome re su l t i ng  from an oat  c e l l  carcinoma of t he  lung 
( f i g .  6-12). 
given an acute water load at a time when h i s  serum sodium w a s  130 mEq/ 
l i t e r .  Essent ia l ly  no change occurred i n  the  ur ine osmolali ty.  The 
ur inary ADH decreased (but did not disappear) and remained present  even 
though the  serum sodium f e l l  from 130 t o  120 mEq/liter during t h i s  t i m e .  
Thus, some degree of i nh ib i t i on  of the  ADH excret ion was observed i n  
response t o  the  water load,  suggesting t h a t  the tumor i n  t h i s  pa t i en t  
was p a r t i a l l y  responsive t o  a normal regulatory mechanism. 
The methodology f o r  determination of urinary ADH w a s  evident ly  ver i -  
f i e d  by the  s tud ies  performed. Urine can be concentrated t o  r a i s e  the  
l e v e l  of ADH i n  the  specimen t o  the  l e v e l  of s e n s i t i v i t y  of t he  assay. 
By using t h i s  technique, it i s  possible t o  measure quant i ta t ive ly  changes 
i n  ur inary ADH excretion t h a t  would be expected t o  occur i n  response t o  
physiological  s t imul i  and thus make possible study of the  r o l e  of ADH i n  
water regulat ion.  
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TABLE 6-1.- REXOVERY OF VASOPRESSIN AFTER EXTRACTION 
ON CT-50 COLUMN ' 
Assay 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
Mean 
Standard deviat ion 
Standard e r r o r  of mean 
L V P - ~ ~ ~ I  
r e  c ove r e  d , 
percent 
91.0 
90.0 
90.1 
89.4 
89.9 
85.2 
94.3 
87.8 
84.7 
87.6 
93.4 
89.4 
3.0 
0.9 
AVP 
r e  covered , 
percent 
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10 4 
94 
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88 
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92 
98 
-- 
-- 
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Figure 6-1.- Radioimmunoassay using AVP as the  standard 
(semilogarithmic p l o t ) .  
p rec ip i t a t ed  decreases as increasing amounts of AVP 
a re  added. The percent p rec ip i t a t ed  when no AW i s  
added i s  indicated by the  point t o  the  r i g h t  of the  
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p lo t .  
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Figure 6-2.- Standard curve using albumin-coated charcoal t o  separate  
antibody bound from f r e e  LVP- 1251. 
charcoal increases  as increasing amounts of AVP a re  added. 
The percent of LVP-~*~I bound t o  
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Figure 6-3.- Comparison of the  r e l a t i v e  a b i l i t y  of AVP, LVP, 
phenylalanine-2 LVP, and oxytocin t o  decrease the  percent 
of prec ip i ta ted .  . 
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Figure 6-4.- Comparison of rat pos te r ior -p i tu i ta ry  con- 
t e n t  of AW as determined by immunoassay with AVP 
content of t he  same specimen as determined by bio- 
assay. 
hydrated rats and from animals subjected t o  water 
deprivation f o r  as long as 4 dws .  
P i t u i t a r i e s  were obtained from normally 
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Figure 6-5.- Comparison of plasma content of AVP as deter- 
mined by immunoassay and by a n t i d i u r e t i c  b i o a s s w  of the  
same specimens. Known amounts of AW were added t o  
a l iquots  of a pooled plasma sample. 
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Figure 6-6.- Comparison of ur inary ADH content as deter- 
mined by immunoassay and by an t id iu re t i c  bioassay of 
the  same specimens. Urine w a s  obtained from rats 
t h a t  were normal o r  had varying degrees of diabetes 
insipidus.  
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Figure 6-7.- The 24-hour ur inary excretion of AVP i n  
normal rats and i n  rats heterozygous o r  homozygous 
f o r  diabetes insipidus.  
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Figure 6-8.- Relationship between 24-hour ur inary 
ADH excretion and u r ine  osmolality ( top )  and 
24-hour ur ine volume (bottom) i n  normal rats 
and rats heterozygous o r  homozygous f o r  
diabetes insipidus.  
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Figure 6-9.- Urinary ADH excret ion response f o r  
24-hour period i n  t he  three  types of rats t o  
water deprivation and t o  subsequent f r e e  access 
t o  water. Normal and heterozygous rats were 
dehydrated f o r  4 days while rats homozygous 
f o r  diabetes insipidus were dehydrated f o r  
2 days, 
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Figure 6-10.- Urinary ADH excretion i n  human subjects .  
The normal individuals  were s tudied under conditions 
of normal a c t i v i t y ,  ea t ing ,  and drinking; and again 
a f t e r  o r a l  water loading. 
inappropriate  ADH syndrome re su l t i ng  from an oat 
c e l l  carcinoma of t h e  lung and th ree  pa t i en t s  
w i t h  severe cen t r a l  diabetes insipidus were a l s o  
s t udie d. 
Two pa t i en t s  w i t h  
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Figure 6-11.- Response of urine volume, osmolali ty,  and 
ADH excretion t o  a maintained o r a l  water load i n  a 
normal subject .  Urinary ADH excretion becomes 
undetectable during the period of maximum d iu res i s  
and reappears following discontinuation of t h e  
water load. 
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Figure 6-12.- Response of ur ine volume, osmol- 
a l i t y ,  and ADH excret ion t o  a s ing le  water load 
i n  a 65-year-old m a l e  pa t i en t  w i t h  inappropri- 
ate ADH syndrome re su l t i ng  from an oat c e l l  
carcinoma of t h e  lung. 
excret ion decreased, it s t i l l  remained detect-  
able desp i te  marked hyponatremia and plasma 
hyp oo s mol a l i  t y  . 
Although ur inary ADH 
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7. HUMAN VASOREGULATION BY R E N I N ,  
ANGIOTENSIN, AND ALDOSTERONE 
By Edgar Haber, M.D.* 
INTRODUCTION 
A f’undamental problem i n  the  study of t h e  hormonal cont ro l  of 
vasoregulation i s  the  capab i l i t y  t o  measure minute blood concentrations 
of c i r c u l a t i n g  polypeptides and s t e r o i d  hormones. The i n a b i l i t y  t o  
quantify the  l e v e l s  of some hormones and t h e  necessity t o  withdraw l a rge  
volumes of blood t o  measure o thers  have made de ta i l ed  physiological in- 
ves t iga t ions  of t he  response of man t o  varying stress most d i f f i c u l t .  
It would be des i rab le  t o  study man on a tilt t a b l e ,  under conditions of 
a l t e r e d  g rav i ty ,  o r  under lower-body negative pressure ,  and t o  obtain 
multiple samples over b r i e f  i n t e r v a l s  f o r  use i n  t h e  determination of 
aldosterone, angiotensin,  and renin without changing blood volume ap- 
preciably.  A general  technique, radioimmunoassay, allows f o r  such 
s tud ie s .  
I n  the first p a r t  of t h i s  r epor t ,  human physiological s tud ie s ,  using 
the  radioimmunoassays f o r  angiotensin I and 11, w i l l  be discussed; i n  t h e  
second p a r t ,  t he  development of a radioimmunoassay f o r  aldosterone w i l l  
be de ta i led .  It i s  hoped t h a t  f’uture s tud ie s  combining these  methods i n  
human investigation will yield new insights into vasomotor regulation. 
RENIN AND ANGIOTENSIN 
Angiotensin I1 i s  measured by means of a d i r e c t  radioimmunoassay 
that has t h e  capab i l i t y  of quantifying normal l e v e l s  ( r e f .  7-1). 
a c t i v i t y  i s  measured by generation of angiotensin I ,  t h e  f i r s t  product 
of t h e  a c t i v i t y  of t h i s  enzyme, during i n  v i t r o  incubation of plasma, 
employing endogenous subs t r a t e  (refs. 7-2 and 7-3) .  Renin a c t i v i t y  i s  
expressed as the amount of angiotensin I produced per  hour of incubation. 
Renin 
*Associate Professor of Medicine, Harvard Medical School; Chief, 
Cardiac Unit, Massachusetts General Hospital ,  Boston, Massachusetts 02114. 
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A study of 15 young, normal volunteers i s  summarized i n  f igure  7-1. 
Blood samples were obtained on awakening, i n  the supine pos i t ion ,  and 
after 4 hours of upright a c t i v i t y .  
from severe r e s t r i c t i o n  t o  excess. A t  the end of the  study, a potent 
d iu re t i c ,  furosimide, w a s  given. Blood samples were obtained f o r  t he  
determination of angiotensin I1 and renin a c t i v i t y ,  and ur ine was col- 
l ec ted  fo r  the determination of aldosterone. Urinary aldosterone w a s  
measured by use of a double-isotope-derivative method. These s tudies  
confirmed e a r l i e r  observations ( ref .  7-4) t h a t  renin a c t i v i t y  responds 
t o  sodium intake and posture.  
fo r  t he  f irst  t i m e  t h a t  c i r cu la t ing  angiotensin I1 leve l s  c losely follow 
renin a c t i v i t y ,  although changes i n  renin a c t i v i t y  appear t o  go through 
a wider range ( f ac to r  of 10) than do venous angiotensin I1 leve ls .  This 
difference may r e l a t e  t o  blunt ing of venous angiotensin concentrations 
by extract ion o r  degradation i n  capi l la ry  beds. 
follows renin a c t i v i t y  and angiabensin I1 changes i n  the  expected manner 
because angiotensin I1 i s  believed t o  be the  major hormone t h a t  regulates  
aldosterone l eve l .  
Dietary intake of sodium was var ied 
Cohen e t  alii (ref .  7-4) demonstrated 
Urinary aldosterone 
I n  summary, a change in  "effective blood volume" by e i the r  upright 
posture or  sodium r e s t r i c t i o n  s t imulates  the  re lease  of renin by t h e  
kidney, which i n  turn  results i n  angiotensin I production and conversion 
t o  angiotensin I1 and s t imulat ion of t h e  adrenal cortex by the angioten- 
s i n  I1 t o  secre te  aldosterone. 
A v i t a l  question, previously unanswered, i s  whether t h i s  system 
a f f e c t s  moment-to-moment vasomotor regulat ion,  o r  whether it a f fec t s  
only long-term "background" changes i n  blood volume. To answer t h i s  
question, an experiment w a s  designed i n  which normal human volunteers 
were subjected t o  short-term pos tura l  stress on a tilt t ab le  ( r e f .  7-5). 
Several pa t ien ts  wi th  cardiac valvular  disease a l so  were s tudied;  i n  
these pa t i en t s ,  rend-ve in  blood samples could be obtained during the 
course of ordinary cardiac ca the te r iza t ion .  Pulse,  blood pressure,  and 
renin a c t i v i t y  were measured after supine rest f o r  0.5 hour, followed by 
frequent samples after upright t i l t i n g  t o  80°. 
Table 7-1 shows t h a t ,  although 27 of 36 subjects  .remained a l e r t  
throughout 30 minutes of upright t i l t i n g ,  nine individuals  fa in ted ,  
necess i ta t ing  termination of tilt e a r l i e r  than 30 minutes. The individ- 
ua l  responses of a typ ica l  normal responder and of a f a i n t e r  are given 
i n  f igures  7-2 and 7-3, respect ively.  A summary of the response of a l l  
volunteers i s  shown i n  f igure  7-4. 
sponse w a s  characterized by a rise i n  pulse r a t e ,  and i n  d i a s t o l i c  blood 
pressure,  accompanied by a s ign i f i can t  increase i n  renin a c t i v i t y .  After 
re turn  t o  the  supine pos i t ion ,  a rap id  re turn  of both hemodynamic param- 
eters and renin a c t i v i t y  t o  normal w a s  observed. Conversely, t he  f a in t -  
ing group had a decrease i n  pulse r a t e ,  a narrowing of pulse pressure,  a 
It i s  evident t h a t  t h e  normal re- 
. 
7-3 
reduction i n  s y s t o l i c  pressure ,  and a much less s i g n i f i c a n t  r ise i n  ren in  
a c t i v i t y .  Renin a c t i v i t y  rises paradoxically after r e tu rn  of t h e  subjec t  
t o  the  supine pos i t i on .  
sponders and f a i n t e r s  with respect t o  maximum renin l e v e l s  i s  documented 
i n  f igu re  7-5. 
the f a i n t e r s  achieved a m a x i m a l  increase of only 49 percent ,  t h e  r ise 
generally occurring a f t e r  r e tu rn  t o  t h e  supine pos i t i on .  
m a l  response t o  t i l t i n g  i n  an anephric sub jec t ,  though no ren in  i s  pres- 
e n t ,  i s  depicted i n  f igu re  7-6. 
i s  poss ib le  i n  t h e  absence of t he  renin mechanism. 
The noteworthy d i f fe rence  between normal re- 
Whereas normals increased by an average of 283 percent ,  
A rather nor- 
Apparently , a normal pos tu ra l  response 
Renal-vein measurements , shown i n  t a b l e  7-11 , a re  ind ica t ive  t h a t  
renal-vein renins a re  w e l l  r e f l e c t e d  i n  peripheral-vein ren in  l e v e l s ,  
although t h e  former are somewhat higher than the  l a t t e r ,  as expected. 
The same kind of d i f fe rences  is  evident between normal responders and 
ind iv idua ls  who f a i n t .  
This study i s  ind ica t ive  t h a t  t he  renin-angiotensin system pa r t i c -  
i p a t e s  i n  the  acute response t o  pos tura l  change i n  normal man and t h a t  
it functions abnormally i n  vasovagal syncope. That the system i s  not 
the so l e  regula tor  of hemodynamics i n  r e l a t i o n  t o  posture i s  ind ica ted  
c l ea r ly  by t h e  a b i l i t y  of some anephric individuals t o  t o l e r a t e  t he  up- 
r i g h t  pos i t i on .  It i s  l i k e l y  that  neurogenic mechanisms and the cate- 
cholamines are a major contributory f ac to r  i n  vasomotor regula t ion  under 
these  circumstances. 
ALDOSTERONE 
I -  
It i s  evident t h a t  experiments i n  which an attempt was made t o  define 
f ac to r s  regula t ing  vasomotor tone would be more meaningful (and c e r t a i n l y  
m o r e  i nc lus ive )  i f  the renin-angiotensin e f f e c t o r  loop could be closed by 
t h e  inc lus ion  of plasma-aldosterone measurements. Aldosterone i s  present 
i n  normal man i n  a concentration of only 50 pg/ml ( r e f .  7-6 ) .  Double- 
isotope-derivative methods f o r  blood necess i t a t e  t he  use of such l a rge  
sample volumes t h a t  t h e  physiological experiment i s  perturbed by reduc- 
t i o n  of blood volume by exsanguination, and r e p e t i t i v e  measurements are 
impossible. 
s i m i l a r i t y  of t he  s t r u c t u r e  of aldosterone t o  o the r  c i r c u l a t i n g  s t e r o i d s  
present i n  far higher concentration i n  blood ( c o r t i s o l  and cor t icos te rone  , 
f i g .  7-7) has necess i ta ted  t h e  combination of chromatographic separations 
with immunoassay. A simple, d i r e c t  immunoassay i s  considered e s s e n t i a l  
i n  t he  e f f e c t i v e  pursu i t  of physiological s tud ie s  i n  man and development 
has been sought of a tes t  tha t  would avoid a l l  p r i o r  chromatography or 
concentration and t h a t  uses minimal volumes of blood. 
An unextracted immunoassay would be des i r ab le ,  but t h e  
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I It has been shown previously t h a t  s t e r o i d  antibodies a re  capable of 
having great s p e c i f i c i t y .  Figure 7-8 i s  ind ica t ive  t h a t  an antibody t o  
digoxin binds d ig i tox in  considerably l e s s  w e l l  (by a f a c t o r  of 501, 
although t h e  two compounds d i f f e r  only by a s ing le  hydroxyl group a t  po- 
s i t i o n  12 on the  s t e r o i d  r ing  ( ref .  7-7 ) .  
differs from digoxin by l o s s  of t h ree  digitoxose sugars,  binds t o  an t i -  
body nearly as wel l  as digoxin. 
molecule i s  recognized i n  one instance and a l a r g e r  change i s  not recog- 
nized i n  the  o ther  ins tance  i s  explained by the  s t ruc tu re  of t he  immuno- 
gen. Antibody t o  digoxin i s  r a i s e d  by coupling the  sugar end of t h e  
molecule t o  a pro te in  c a r r i e r  and by i n j e c t i n g  animals with t h i s  protein- 
s t e r o i d  conjugate. Antibodies are elaborated t h a t  have g rea t e s t  spec i f ic -  
i t y  f o r  t he  portions of t h e  molecule distal  t o  the  c a r r i e r  pro te in  ( t h e  
steroid-lactone) and least s p e c i f i c i t y  f o r  those p a r t s  nearest  t he  c a r r i e r  
( t he  suga r s ) .  
Conversely, digoxigenin, which 
I The reason why a s m a l l  change i n  t h e  
A study of t h e  s t r u c t u r e  of aldosterone and s i m i l a r  compounds i n  
f igure  7-7 i s  c l ea r ly  ind ica t ive  t h a t  antibodies l i k e l y  t o  have s u f f i c i e n t  
s p e c i f i c i t y  f o r  d i f f e r e n t i a t i n g  aldosterone from other  c i r cu la t ing  s t e ro ids  
must have t h e i r  major s p e c i f i c i t y  d i rec ted  toward s t ructures  i n  the D-ring. 
The most logical site of coupling i s  pos i t ion  3.  This coupling w a s  accom- 
plished by forming a steroid-hydrazone with aldosterone under conditions 
4 such t h a t  the  A -3 ketone p r e f e r e n t i a l l y  reac ted  r a t h e r  than the  C20 ke- 
tone ( r e f .  7-8 ) .  The general ou t l i ne  f o r  synthesis of t he  immunogen i s  
shown i n  f igu re  7-9. Analysis of t h e  r e s u l t i n g  compound w a s  i nd ica t ive  
t h a t  a unique s u b s t i t u t i o n  at pos i t ion  3 had occurred. Relative displace- 
ment by various s t e ro ids  fo r  an antibody produced by immunization with 
t h i s  antigen i s  shown i n  f igu re  7-10; 25 pg of unlabeled aldosterone re- 
su l t ed  i n  15-percent displacement of l a b e l  , a s e n s i t i v i t y  s u i t a b l e  f o r  
d i r e c t  plasma assay. However, c o r t i s o l  and cor t icos te rone ,  s t e r o i d s  of 
very s i m i l a r  s t r u c t u r e ,  required a 10 000-fold or g r e a t e r  concentration 
f o r  equal displacement. Other s t e r o i d  compounds were even l e s s  
cross-reactive. 
CONCLUSIONS 
The a v a i l a b i l i t y  of antibodies of such s p e c i f i c i t y  and a f f i n i t y  
soon w i l l  permit t he  development of s e n s i t i v e ,  d i r e c t  radioimmunoassays. 
It is  hoped t h a t  fu tu re  examination of pos tu ra l  re f lexes  i n  man w i l l  in- 
clude serial blood-aldosterone determinations as w e l l  as ren in  and angi- 
otensin I1 determinations. Improved ana ly t i c  techniques f o r  studying 
hormonal vasoregulation w i l l  result i n  understanding cont ro l l ing  these  
re f lexes  t h a t  a r e  so important t o  maintenance of m a x i m a l  e f f i c i ency  dur- 
ing  a l t e r e d  g rav i ty  states. l 
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TABU 7-1.- CLASSIFICATION OF SUBJECTS AND THEIR RESPONSE 
[From r e f .  7-53 
-~ 
Normal volunteers 
Catheter izat ion pa t ien ts  
Anephri cs 
Totals 
Class of subjects  
16 
7 
4 
27 
Normal 
response Faint 
TO TILTING 
20 
11 
5 
36 
. 
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Figure 7-1.- Renin a c t i v i t y  measured as an- 
giotensin I produced, venous angiotensin 
11, and aldosterone excretion i n  15 nor- 
m a l  sub jec ts  under varying "stress" t o  
"effect ive blood volume." Sodium values 
represent intake per  24 hours (from r e f .  
7-31 
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Figure 7-2.- Typical response t o  tilt- 
i n g  i n  a normal subject  who did not 
f a i n t .  The v e r t i c a l  l i n e  ind ica tes  
when supine posture was resumed. 
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Figure 7-3.- Typical response t o  t i l t i n g  
in a subject  who fa inted.  
placed supine at 7 minutes. 
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. 
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Figure 7-4.- Mean renin a c t i v i t y ,  pulse rate, and 
s y s t o l i c  and d i a s t o l i c  blood pressure f. standard 
e r r o r  of t h e  mean f o r  t h e  normal volunteers are 
p lo t t ed  against  time. Values f o r  normal respon- 
ders are  represented by closed c i r c l e s  connected 
by s o l i d  l i n e s ;  f o r  f a i n t e r s ,  by open c i r c l e s  
connected by dashed l i n e s .  All values are ex- 
pressed as percent of base l i n e  (from re f .  7-5). 
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Figure 7-5. - Maximum renin a c t i v i t y  following upright 
t i l t i n g  f o r  all subjects  studied. Each renin value 
i s  represented as percentage change from base-line 
l e v e l  fo r  t h e  pa r t i cu la r  subjec t ;  f igures  i n  each 
column r e f e r  t o  t h e  mean ? standard e r ro r .  The 
means were s ign i f i can t ly  d i f fe ren t  ( p  < 0.001) on 
t - t e s t  (from r e f .  7-51. . 
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Figure 7-6.- Renin a c t i v i t y ,  pulse r a t e ,  and blood 
pressure of t he  normotensive anephric pa t ien t  are 
p lo t t ed  against  time (from r e f .  7-5). 
Steroid 
~ 
A Ido sterone 
Corticosterone 
Cortisol 
R1 
-CHO 
-CH3 
-CH3 
R2 
-H 
-H 
-OH 
Figure 7-7. - Structures  of aldosterone, cor t icosterone,  and cor- 
t i s o l .  
i n  a hemiacetal l i nk  with t h e  C (from ref. 7-8). 
The 5 8  (R1) aldehyde of aldosterone e x i s t s  i n  solut ion 
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Figure 7-8.- Hapten-inhibition curves (antiserum 46/97) f o r  
the s t e r o i d  compounds digoxigenin, cholesterol  (CHI cor- 
t i s o l  (CO) ¶ dehydroepiandrosterone (DHA) ¶ 17 8-estradiol  
( E )  ¶ t es tos te rone  ( T )  , and progesterone (PI  , compared w i t h  
t he  homologous hapten digoxin. The value f o r  cholesterol  
represents t h e  concentration at sa tura t ion  of  t h e  aqueous 
buf fer .  The arrow on t h e  ordinate  denotes binding i n  t h e  
absence of unlabeled ligand. 
a re  means, with ranges of dupl icate  determinations as 
shown (from ref. 7-7). 
Individual values p l o t t e d  
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Figure 7-9.- A scheme f o r  synthes is  o f  aldosterone A 4 -3 hydrazino-benzoic 
acid-bovine serum albumin. 
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Figure 7-10 .- Displacement of 3H-aldosterone by 'H-aldosterone and 
by other  s t e ro ids .  
3H-aldosterone and a 1:50 d i lu t ion  of serum from a r a b b i t ,  obtained 
10 weeks a f t e r  i n i t i a l  immunization. 
s t e ro ids ,  61 percent of t he  3H-aldosterone was bound by t h e  antiserum 
(from ref. 7-8). 
Incubation mixtures contained 21 pg of 
In t h e  absence of unlabeled 
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8. HORMONAL CONTROL OF CALCIUM METABOLISM 
By John T. Po t t s ,  Jr., M.D.* 
INTRODUCTION 
Three ana ly t i ca l  techniques are of pa r t i cu la r  i n t e r e s t  i n  t h e  study 
of calcium and bone metabolism; these techniques are t h e  assays f o r  para- 
thyroid hormone, ca lc i ton in ,  and vitamin D. Discussion w i l l  be l imi ted  
t o  t h e  current methods of assay and t h e  uses t o  which the  assays might 
be put .  
DISCUSSION 
The parathyroid hormone ( P T H )  radioimmunoassay has been used f o r  a 
number of years .  Methods have been developed i n  severa l  independent lab- 
o ra to r i e s ,  and the assay i s  proving t o  be very useful  (refs. 8-1 t o  8-6). 
A t y p i c a l  assay result i s  shown i n  f igure 8-1. 
can be detected i n  all normal pa t i en t s ;  however, pa t i en t s  with both pr i -  
mary and secondary disorders of t h e  parathyroid function usual ly  have 
much higher PTH assay l eve l s .  It has a l so  become evident t h a t ,  as these  
tests are applied t o  define more closely t h e  abnormality i n  hyperpara- 
thyroidism, problems appear. The range of PTH values found i n  normal 
subjects  i n  the immunoassay (expressed i n  terms of a standard preparation 
of human FTH) average 0.6 t o  0.7 ng/ml. 
r e s t ing  state f o r  a number of pa t i en t s  w i t h  primary hyperparathyroidism 
are shown i n  figure 8-1. 
higher than those found i n  normal individuals ,  but an overlap de f in i t e ly  
e x i s t s .  This overlap i n  PTH values i s  minimized i f  a correct ion i s  made 
f o r  basal blood calcium ( f i g .  8-1). Of all those working w i t h  t h e  im- 
munoassay technique, only Reiss and Canterbury (ref.  8-3) have indicated 
t h a t  no overlap e x i s t s .  The reasons f o r  t h i s  w i l l  be discussed later. 
The disagreement m a y  be i n t r i n s i c  t o  t h e  problem of the  nature of immuno- 
reac t ive  hormone rather than t o  any assay technique. 
d i f f e ren t  inves t iga tors  are measuring d i f f e ren t  f rac t ions  of hormone t h a t  
i s  not behaving as a s ing le  component i n  t h e  blood. 
The FTH concentrations 
The PTH values found during t h e  
As can be seen, most PTH values are much 
It would seem t h a t  
"Chief, Endocrine Unit, Massachusetts General Hospital ,  Boston, 
Massachusetts 02114. 
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The problem becomes important i n  the  aerospace appl icat ion of t he  
procedure, both from the viewpoint of improving t h e  accuracy of t he  diag- 
nos t ic  tes t  f o r  dis t inguishing c l ea r ly  normal from abnormal functioning 
and, i n  t h e  case of men exposed t o  weightlessness, f o r  es tab l i sh ing  very 
c l ea r ly  t h e  l i m i t s  of abnormal functioning. The problem of overlapping 
values, which may i n  p a r t  be caused by immunochemical heterogeneity, w i l l  
have t o  be solved. 
When a parathyroid adenoma i s  removed from a pa t ien t  with primary 
hyperparathyroidism, the expectation i s ,  on t h e  bas i s  of e a r l i e r  inves t i -  
gations i n  which animals were used ( r e f .  8-71, t o  see the hormone concen- 
t r a t i o n  decrease very sharply i n  a monotonic fashion t o  undetectable o r  
very low l eve l s .  I n  each of 20 pa t i en t s  from whom a parathyroid adenoma 
had been removed, a rap id  decrease i n  hormone concentration was noted 
i n i t i a l l y ,  which indicated the removal of the source of hy-persection. 
However, a f l a t t en ing  out i n  the rate of decrease of hormone concentration 
occurred and w a s  followed by the disappearance of the second component(s) 
f r o m  blood w i t h  a m u c h  s l o w e r  h a l f - t i m e  ( T  1/2). The i n i t i a l  T 1/2 i s  on 
the order of approximately 15 t o  18 minutes, and t h e  second T 1 /2  is sev- 
eral hours ( f i g .  8-2). 
The problem i s  even worse f o r  pa t i en t s  w i t h  chronic rena l  failure 
( f i g .  8-31, who of ten  have increased PTH l eve l s  because of secondary hyper- 
parathyroidism. The data points  indicated by f i l l e d  c i r c l e s  represent t he  
concentration of immunoassayable hormone i n  the  blood f o r  a pa t i en t  with 
chronic r ena l  failure and from whom. a l l  four  parathyroids were removed at 
t h e  judgment of t he  p a t i e n t ' s  physicians because of severe bone disease 
and other  complications. The data points  indicated by open c i r c l e s  rep- 
resent  t he  p a t i e n t ' s  serum calcium, which w a s  at a preoperative l e v e l  of 
10.5 milligram-percent. Approximately 100 minutes after t h e  parathyroid- 
ectomy w a s  performed, an abrupt decrease of t he  pa t i en t ' s  calcium concen- 
t r a t i o n  t o  t e t a n i c  l eve l s  was observed. Yet, the hormone w a s  disappearing 
from the  blood very slowly, with no fast component at all. A t  t h e  t i m e  
the  pa t i en t  experienced symptoms of te tany ,  t he  immunoassayable hormone 
i n  the  blood w a s  s t i l l  present i n  the hyperparathyroid range. 
AII even more severe example ( f i g .  8-4) i s  taken from some stimula- 
t i o n  and suppression tests i n  another pa t i en t  with chronic r ena l  f a i l u r e  
( i n  t h i s  case, immediately a f t e r  successful  rena l  t ransplan ta t ion) .  
When calcium was infused ( f i g .  8-4(a)) t o  raise t h e  calcium l e v e l  from 
approximately 10 t o  1 4  milligram-percent, hardly any change i n  t h e  
immunoassayable-hormone concentration i n  the  blood resul ted.  However, 
when an ethylenediaminetetracetic ac id  (EDTA) infusion was  given 
( f i g .  8-4(b)) t o  lower the ionized calcium and t o  stimulate t h e  hyperplas- 
t i c  parathyroid glands, a sudden rise i n  the  immunoassayable-hormone concen- 
t r a t i o n  w a s  observed. This phenomenon seems t o  ind ica te  t h a t ,  at any one 
t i m e ,  a pool of mater ia l  i s  present i n  t h e  blood t h a t  cons is t s  of at least 
c 
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two components, both of which a re  being measured. One component i s  be- 
having as though it i s  hormone recent ly  re leased  from t h e  gland, disap- 
pearing from blood quickly when gland-secretory a c t i v i t y  i s  suppressed 
o r  parathyroid t i s s u e  i s  removed. Another component, which i s  present 
i n  var iab le  concentrations, has a very slow metabolic clearance. I n  t h e  
chronic-renal-failure pa t i en t  who i s  t r e a t e d  with EDTA, it i s  very easy 
t o  witness an increase  i n  t h e  t o t a l  pool. However, because, under b a s a l  
conditions,  t h e  concentration of t h e  rap id ly  cleared mater ia l  i s  q u i t e  
small i n  r e l a t i o n  t o  t h e  t o t a l  pool of immunoreactive hormone, it i s  dif- 
f i c u l t  t o  de tec t  a decrease, even when new hormone r e l ease  i s  abolished. 
This phenomenon does not mean tha t  t h e  assay i s  detecting nonparathyroid- 
r e l a t e d  peptides.  In  p a t i e n t s  without parathyroid glands, no immuno- 
r eac t ive  hormone i s  detected.  I f  a p a t i e n t ' s  hormone l e v e l  i s  observed 
a f t e r  a parathyroid adenoma i s  removed, it w i l l  be noted t h a t ,  after an 
i n i t i a l  r ap id  f a l l ,  t h e  hormone l e v e l  decreases slowly t o  normal or  un- 
de tec tab le  l e v e l s  a f t e r  a period of days. Berson (ref.  8-8) has dis- 
cussed t h i s  o v e r a l l  phenomenon, and t h e  problem of immunoreactive and 
metabolic heterogeneity of plasma parathyroid hormone i s  being s tudied  
by many inves t iga to r s .  The problem was the  subject of a recent review 
at t h e  Mayo Cl in ic  i n  Rochester, Minnesota ( r e f .  8-41, a t  which similar 
phenomena were discussed. 
O f  addi t iona l  i n t e r e s t  i s  the  finding tha t  parathyroid adenomas are  
not at a l l  f ixed  and autonomous i n  t h e i r  hormone output, with respect t o  
e i t h e r  st imulation or suppression ( r e f .  8-4). 
t i e n t s  w i t h  a parathyroid adenoma (proven at surgery) who had been given 
EDTA stimulation i s  shown i n  f i g u r e  8-5. 
mates t h e  proportional type of cont ro l  t h a t  i s  seen i n  normal subjec ts ,  
i s  observed i n  immunoassayable-hormone concentration. It i s  presumed 
t h a t  some por t ion  of t h e  hormone detected i n  t h e  basal s t a t e  corresponds 
t o  t ha t  observed i n  the pa t i en t  who has chronic rena l  f a i l u r e ;  t h a t  i s ,  
t h e  material cons is t s  of one component t h a t  disappears s l o w l y  and another 
component t h a t  cons is t s  of hormone recent ly  released from the gland. It 
i s  be l ieved  that  what i s  observed i s  the  increase of recent ly  secre ted  
hormone a f t e r  EDTA stimulation. A more extreme phenomenon i s  observed 
i n  t h e  suppression tests ( f i g .  8-6). Many p a t i e n t s  w i t h  parathyroid 
adenomas who were given a calcium infus ion  experienced a b r i s k ,  but 
only p a r t i a l ,  suppression of hormone concentration. Again, t h e  assump- 
t i o n  i s  made that  the  observed phenomenon does not i nd ica t e  incomplete 
suppression but  r a t h e r  an immediate cessation of output from t h e  gland, 
followed by a gradual decrease i n  the concentration of slowly metabolized 
material. The slowly metabolized ma te r i a l  has a very slow metabolic r a t e ,  
analogous t o  t h e  pers i s tence  of immunoreactive hormone material with a 
slow disappearance T 1 / 2  i n  pa t i en t s  from whom abnormal parathyroid glands 
have been removed. I n  p a t i e n t s  w i t h  ch ie f -ce l l  hyperplasia,  t h e  hormone 
concentration i s  a l s o  suppressed. This instance i s  t h e  second for which 
f ind ings  a re  i n  apparent disagreement with those of Reiss and Canterbury 
A t y p i c a l  example of pa- 
A very b r i s k  r ise which approxi- 
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( r e f .  8-3), who have observed tha t  t h e  adenomas invariably produce a 
completely f ixed ,  constant output of hormone, but t h a t  t h e  output of 
hyperplastic glands can be suppressed. 
One o ther  point of i n t e r e s t  i s  t h a t  very use fu l  information has been 
gained from the  EDTA t e s t s ,  even though these  tes ts  a re  not he lpfu l  f o r  
t e s t i n g  autonomy. It has been learned t h a t  t h e  EDTA challenge t e s t  can 
be used as an approximate ind ica t ion  of t he  amount of parathyroid t i s s u e  
present.  
hormone concentration, i s  closely r e l a t e d  t o  t h e  s i z e  of t i s s u e  found 
subsequently a t  surgery. For example, t h e  hormone l e v e l  of a pa t i en t  
with a s m a l l  adenoma and whose l e v e l  rose  from 0.7 t o  1.5 ng/ml with EDTA 
stimulation i s  shown i n  f igu re  8-7(a). These data can be contrasted t o  
t h e  changes t h a t  occurred i n  another p a t i e n t  whose i n i t i a l  hormone con- 
cent ra t ion  w a s  3 ng/ml and rose t o  17 ng/ml ( f i g .  8-7(b)).  This cont ras t  
i s  made more obvious i n  f igu re  8-8, i n  which t h e  responses i n  t h e  two 
p a t i e n t s  are p l o t t e d  on the  same sca l e .  The magnitude of t h e  response i n  
t h e  second p a t i e n t  i s  so  enormous as t o  make t h e  response of t h e  f i r s t  
pa t i en t  seem negl ig ib le .  Thus, some ins igh t  i n t o  parathyroid reserve and 
i n t o  the degree of enlargement of t h e  parathyroids can perhaps be gained 
by t h e  use of these  t e s t  methods. 
The response, i n  terms of t h e  r i s e  i n  t h e  immunoassayable- 
The t e s t  data exemplify the  types of s i t u a t i o n s  t h a t  are present ly  
being studied. Despite t h e  inherent d i f f i c u l t i e s  i n  t h e  assay, it ap- 
pears t h a t  t he  g rea t e r  t h e  mass of abnormal parathyroid t i s s u e  and, i n  
general ,  t h e  more severe t h e  hyperparathyroidism, t h e  g rea t e r  t h e  b a s a l  
concentrations of hormone w i l l  be,  compared w i t h  hormone-concentration 
values found i n  normal subjec ts .  The EDTA provocation t e s t  i s  par t icu-  
l a r l y  usefu l ,  because decisions about t h e  existence of abnormalities i n  
glandular function can be made much more e a s i l y  i f  measurements a re  made 
of t h e  amount of hormone t h a t  i s  present i n  t h e  blood on t h e  extreme of 
t h e  response curve, a t  which point t h e  d i f fe rence  between normal and ab- 
normal i s  magnified. 
The meaning of t h e  observations concerning immunochemical hetero- 
geneity has not been c l e a r l y  es tab l i shed .  It seems l i k e l y  t h a t  what i s  
being measured as PTH i n  t h e  blood i s  t h e  r e s u l t  of a combination of t h e  
sec re t ion  of newly biosynthesized hormone and t h e  metabolic degradation 
of t h e  hormone a f t e r  r e l ease  from the  gland. The hormone released from 
t h e  gland i s  cleared perhaps through enzymatic digestion, bu t  t h e  u l t i -  
mate d isposa l  of some of these  cleavage products or fragments may be a 
r e l a t i v e l y  slow s t ep .  Fragments may be bound t o  plasma pro te in ,  may be 
c i r cu la t ed  i n  t h e  blood as self-aggregates, or simply may be cleared 
from t h e  blood very slowly. 
i n t e r f e r e s  w i t h  assessment of t h e  secre tory  a c t i v i t y  of t h e  gland after 
suppression by calcium infusion. 
The pers i s tence  of some of t h i s  mater ia l  
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A reso lu t ion  of the  explanation f o r  t h e  heterogeneity of plasma FTH, 
however, now seems qu i t e  possible.  Recent developments, with respect t o  
t h e  s t r u c t u r e  and synthes is  of FTH, have opened t h e  way t o  resolving t h e  
chemical nature of t h e  various forms of c i r cu la t ing  PTH. 
amino-acid sequence of t h e  bovine hormone has been determined ( f i g .  8-9), 
and t h e  amino-acid sequence of t h e  porcine hormone has a l s o  been deter- 
mined ( f ig .  8-10). The amino-acid sequence i n  t h e  amino terminal region 
i s  t h e  sequence t h a t  i s  important f o r  b io log ica l  a c t i v i t y  of t h e  hormones. 
Using t h e  technique of solid-phase peptide synthes is ,  Dr. G. W. Tregear 
has j u s t  completed a successful sequence of the 1-to-34 sequence of PTH 
and has produced what i s  believed t o  be a preparation of syn the t i c  hor- 
mone tha t  i s  highly ac t ive  both i n  vivo and i n  v i t r o  on bone and kidney. 
This synthesis of hormone fragments should make poss ib le  systematic ex- 
amination of the nature of the c i r cu la t ing  fragments of hormone by using 
d i f f e r e n t  region-specific immunoassays t h a t  a re  prepared by immunization 
w i t h  s e l ec t ed  sequences of t he  hormone. 
immunochemical heterogeneity can be approached d i r e c t l y ,  and decisions 
can be made as t o  whether t h e  material t h a t  slowly disappears from t h e  
blood represents  a s p e c i f i c  por t ion  of t h e  amino-acid sequence. Then, 
t ha t  por t ion  of t h e  sequence could be measured or not measured, depending 
on which antiserum i s  used i n  the assay system. 
have already been synthesized f o r  t he  purpose of making fragment-specific 
antibodies;  namely, t h e  1-to-13, 14-to-34, 19-to-34 , and 25-to-34 sequen- 
ces. Thus, i n  addi t ion  t o  making the ac t ive  fragment f o r  b io log ica l  work, 
t h e  sequence i s  being completed region by region f o r  use i n  t h e  immuno- 
assay study. 
The complete 
In t h i s  way, t h e  problem of 
Certain por t ions  of PTH 
Calcitonin Assay 
Various ca l c i ton ins  from severa l  d i f f e ren t  species have been i s o l a t e d ,  
and the  s t ructures  have been determined (ref.  8-9). Although the  s&on 
hormone i s  perhaps t h e  most i n t e r e s t i n g  from a therapeut ic  po in t  of v i e w  
(ref.  8-10), it i s  a human-calcitonin assay t h a t  i s  of primary i n t e r e s t  
from a physiological po in t  of v i e w .  Recently, D r .  L.  3. Deftos has been 
successful i n  developing a very s e n s i t i v e  radioimmunoassay for human cal- 
c i ton in  (refs. 8-11 t o  8-13). 
r e a c t i v i t y  occurs between human and animal ca l c i ton ins .  Therefore, 
although s p e c i f i c  immunoassays f o r  salmon, bovine, porcine, and ovine 
ca l c i ton in  ex i s t ed ,  none w a s  of any use i n  measuring t h e  human hormone. 
A very s e n s i t i v e  immunoassay based on antihuman ca l c i ton in  a n t i s e r a  and 
a s m a l l  amount of the synthe t ic  human hormone w a s  t he re fo re  developed. 
This immunoassay, which can be used t o  de tec t  as l i t t l e  as 10 pg/ml of 
ca l c i ton in  ( f i g .  8-11), has proved q u i t e  s u i t a b l e  f o r  de tec t ion  of the 
ca l c i ton in  concentrations i n  p a t i e n t s  with medullary carcinoma. A s  in- 
d ica ted  on t h e  logarithmic s c a l e ,  t hese  p a t i e n t s  have per iphera l  concen- 
t r a t i o n s  of ca l c i ton in  as high as 100 000 pg/ml, i n  cont ras t  t o  t h e  
I n  cont ras t  t o  the PTH assay, no cross- 
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normal group of p a t i e n t s ,  most of whom have ca l c i ton in  concentrations 
t h a t  are generally undetectable. Despite t h i s  cont ras t ,  it has been pos- 
s i b l e  t o  begin studying t h e  dynamics of ca l c i ton in  i n  man by studying 
pa t i en t s  with medullary thyro id  carcinoma, 
f igu re  8-12, a calcium infus ion  i n  a p a t i e n t  with medullary thyro id  car- 
cinoma r e s u l t s  i n  a marked and very prompt r i s e  i n  immunoassayable cal- 
c i ton in .  Two d i f f e ren t  rates of calcium infus ion  r e s u l t  - a  modest 
increase and a very l a rge  increase  i n  ca l c i ton in .  A s  shown i n  f igure  8-13, 
t h e  tumor i s  responsive i n  both d i r ec t ions ;  t h a t  i s ,  an EDTA infusion t o  
lower the  calcium i n  t h e  blood w i l l  cause a suppression of hormone produc- 
t i o n .  Glucagon has a var iab le  e f f e c t  on immunoassayable ca lc i ton in  i n  
humans. 
as a t o o l  t o  study adaptation of hormone secre t ion  t o  s k e l e t a l  stress 
(e .g . ,  whether ca l c i ton in  secre t ion  increases d i r e c t l y  o r  i n d i r e c t l y  i n  
response t o  increased bone resorp t ion) .  
For example, as shown i n  
With improved techniques, it i s  hoped t h a t  t h e  assay can be used 
Vitamin D Assay 
DeLuca e t  alii ( r e f .  8-14) have revolutionized t h e  a rea  of vitamin D 
study over t h e  last  3 o r  4 years with observations t h a t  support t h e  view 
t h a t  vitamin D i s ,  i n  many ways, more l i k e  a hormone than a vitamin. It 
i s  derived e i t h e r  from t h e  d i e t  o r  endogeneously from t h e  sk in  where an 
inac t ive  precursor,  dehydrocholesterol, i s  converted t o  vitamin D by ir- 
rad ia t ion  from the  sun. Vitamin D ,  however, i s  inac t ive  and requi res  
conversion t o  25-OH vitamin D by a s p e c i f i c  hydroxylase i n  t h e  l i v e r  t o  
exe r t  i t s  physiologic ac t ion .  It would appear t h a t  dihydrotachysterol 
and e rgoca lc i f e ro l  a l s o  undergo such metabolic conversion with s p e c i f i c  
hydroxylation at pos i t i on  25 on t h e  s ide  chain. Furthermore, DeLuca 
e t  alii ( r e f s ,  8-15 and 8-16) have shown t h a t ,  subsequent t o  t h i s  process,  
f u r t h e r  hydroxylation occurs i n  o ther  t i s s u e s  and t h a t  t h e  f i n a l  ac t ive  
products a re  probably dihydroxy metabolites of vitamin D. I n  any study 
of t h e  results of chronic environmental stress or various disease states 
i n  m a n ,  it now seems t h a t  vitamin D metabolism, which i s  o rd ina r i ly  
c lose ly  regulated,  i s  subject t o  cont ro l  a t  multiple poin ts  and, there- 
fo re ,  has many poin ts  at which derangement i n  cont ro l  may occur. The 
r e s u l t  of prolonged sunl ight  deprivation and inadequate vitamin D syn- 
t h e s i s  o r  i n t e r f e rence  with t h e  e f f ic iency  of conversion of t h e  D t o  
t h e  25-OH compound remains t o  be seen. 
por tan t  f i e l d  f o r  inves t iga t ion .  What has been lacking i s  a s e n s i t i v e  
method f o r  chemically measuring 25-OH vitamin D and vitamin D d i r e c t l y .  
Fortunately,  D r .  R .  Belsey has been successful i n  applying a Murphy-type 
saturation-analysis technique t o  t h e  de tec t ion  of vitamin D a t  t h e  phys- 
i o l o g i c a l  l e v e l s  ( r e f .  8-17). A t  t h e  present time, a simple ex t r ac t ive  
3 and chromatographic s t e p  t h a t  separa tes  vitamin D from 25-OH vitamin D 
i s  used. Because both compounds are bound t o  t h e  s p e c i f i c  vitamin-D- 
binding pro te in ,  measurement of t h e  physiological l e v e l s  of both compounds 
3 
These areas cons t i t u t e  a very im- 
3 
I ’ .  
i s  possible  ( f i g .  8-14). 
pro te ins  e x i s t ,  one of which binds vitamin D p re fe ren t i a l ly  while the 
other  p re fe ren t i a l ly  binds 25-OH vitamin D. 
two spec i f i c  l igand systems could be developed f o r  d i r ec t  determination 
of both vitamin D and 25-OH vitamin D without a chromatographic s tep ,  i f  
t h e  separate  vitamin-D-binding pro te ins  can be i so la ted .  
kr ident ly  , i n  man-, severa l  vitamin-D-binding 
Thus, it i s  possible  t h a t  
A t  the present time, the  binding pro te in  from blood has been usefu l  
f o r  detect ion of vitamin D by means of t h e  usual competition between 
tri t ium-labeled vitamin D and added unlabeled mater ia l .  
quant i ty  can be as minute as 1 nanogram of vitamin D which i s  wel l  be- 
low t h e  physiological range. 
series of s tud ies  of vitamin D and i t s  ac t ive  metabolites i n  various dis- 
ease states and -of  pa r t i cu la r  i n t e r e s t  i n  the aerospace s tudies  - 
under various physiological adaptation s i tua t ions  (such as the s k e l e t a l  
stress induced by weightlessness).  
rate of decl ine i n  blood l eve l s  of vitamin D and 25-OH vitamin D i n  the 
t o t a l  absence of sunl ight  or u l t r a v i o l e t  i r r ad ia t ion ,  as i n  prolonged 
space f l i g h t .  
The assayable 
3’ 
This technique can now be applied i n  a 
It w i l l  be important t o  determine t h e  
I -  
I 
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Figure 8-1. Basal fasting-plasma PTH concentration in 30 normal adult 
subjects (0) , 20 patients with primazy hyperparathyroidism (A), and 
six patients with nonparathyroid hypercalcemia (x). 
hand panel, the PTH concentrations are plotted as a function of the 
basal serum-calcium concentration. 
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hyperparathyroidism (as a function of time with T 1 /2  ind ica ted)  
following t h e  removal of a parathyroid adenoma. 
I -  
8-12 
11 - 
E 
0 
0 
l-4 10 > 
.- E 9  
E 
4 
.L) 
4 
II! 
8 8  
S 
S 
0 
0 
E 
.3 7 
2 
6 
u - 
e--- Calcium concentration 
PTH concentration 
1 10 100 1000 10 000 
Time, min 
Figure 8-3. Plasma PTH concentration ( 0 )  and serum-calcium concen- 
tration (0) in a patient with chronic renal failure as a 
function of time after subtotal parathyroidectomy. 
- 14- 
E 
0 
0 
d 
2 
2 
E 10- 
.- 5 
- 1 2 -  
5 
0 .- 
Y 
aJ 
0 
0 - 
d 
8- 
2 
- 
E 
\,1 
S 1  
S 
8 
0 
Y 
. 
.- 
8 
S 
0 
0 
I 
I- 
0. 
Calcium - infusion period 
.o 
.5 
. .o 
- 
' 
- 
* 5  t 
14 
- 
E 
0 
0 
I 4  
\ 12 . 
r 
0 .- 
Y 
Y 
E 
E 1 0 -  
.- 5 
S 
0 
0 
0 - 
d 8 -  
1 I I 1 1 1 
7 8 9 10 11 12 13 
Time,  hr 
01 
- 
- 
P T H  concentration 
- -- - -- Ca I c ium concentration 
2 .o-  
- 
E a 
1.5. 
8 
0 .- 
Y 
5 g 1.0- 
5 
0 
0 
I 
I- 
n .5 
(a)  During calcium infusion. 
' 
E D T A  - infusion period 
- P T H  concentration 
------ Cal c i  um concentration 
% 
0- 
7 8 9 10 11 
Time,  hr 
(b)  During EDTA infusion. 
Figure 8-4. Plasma PTH concentration ( 0 )  and serum-calcium 
concentration (0) i n  a pa t i en t  w i t h  chronic r ena l  failure. 
8-14 
14 
13 
- 
E 
l-l 
\ - E 12 . 
c 
0 
'3 11 
2 
Y - E  10 
c 
0 
0 
9 
-3 8 
5 .- 
0 
4 
- 
E > c 
1 
E D T A -  infusion period 
E13 r 
 - 
0 
0 
d 
$12 
E 
.- 
Y e F 10 
s 9  
5 
V c 
.- 
2 8  m u 
PTH concentration 
Calcium concentrat ion _----- 
-
0 1 2  3 4 24 
Time I hr 
(a )  Pa t i en t  1. 
E D T A -  infusion period 
 
t4 
0 1 2 3 4 5 . 5  
Time I hr 
- PTH concentration 
___--- Ca I c ium concentration 
. 
(b) Pat ien t  2. 
Figure 8-5. Plasma FTH concentration ( 0 )  and serum- 
calcium concentration ( A )  during EDTA infusion i n  - 
two pa t i en t s  with parathyroid adenomas. 
8-15 
Calcium-infusion period 
2 .o 
- 
5 1.5 F 
3 g 1.0 
e .- 
U 
0 
I - 
n. .5 
0 
I 
I- 
n 
EDTA-infusion period 
n 
10 
' I  
I 
I I 
0 1 2 3 4 5  
[(/: .- 05
f lo 
8 
- PTH concentration 
---Calcium concentration 
0 1 2 3  
Time, hr 
Figure 8-6. Plasma PTH concentra- 
t i o n  ( 0 )  and serum-calcium con- 
cent ra t ion  (0) during calcium 
inf'usion i n  a pa t i en t  with a 
parathyroid adenoma. 
- PTH concentration 
------- Calcium concentration 
Time, hr 
(a )  Pa t ien t  1. 
20 
- < 15 
F 
.- s
8 
lo 
I 
t 5  
0 
EDTA-infusion period 
 
- 
E 13 0 
0 :: 12 
F 
i 11 
3 g 10 
Y 
8 9  
s 
E 8  
J 
0 1 2 3 4 5  
Time, hr 
(b) Pa t i en t  2. 
PTH concentration 
CI Ic i um concentrat ion 
Figure 8-7. Plasma PTH concentration ( 0 )  and serum-calcium ( A )  
concentration during EDTA infusion i n  two pa t i en t s  with primary 
hyperparathyroidism. 
8-16 
20 
- 15 
E 
\ 
m r 
r 
0 
. 
I- 
O J 10 c a 
V c 
0 
0 
I 
I- 
n 5  
0 
EDTA- infusion period 
m 
I-- Patient 1 
- Patient 2 
1 2 3 4 5 6 
Time, hr 
Figure 8-8. The PI” concentrations f o r  pa t i en t s  
1 and 2 from f igure  8-7 rep lo t ted  on t h e  same 
sca le  . 
. 
8-17 
N 
30 
Figure 8-9. Amino-acid sequence of bovine 
PTH. Shaded residues represent  the 
region of the  molecule t h a t  exhib i t s  
t h e  b io logica l  a c t i v i t y  of t h e  na t ive  
molecule. 
8-18 
I 
I5 
30 
ASP 
no' 
. 
. 
Figure 8-10. The amino-acid sequence of 
bovine PTH, as compared to the amino- 
acid sequence of porcine PTH. 
differences in the porcine structure 
are represented by the shaded residues. 
The 
. 
8-19 
i . .  0 %  ox A 0  A e  
Cat c i ton i n 
Human 
Porcine 
A Bovine 
x Salmon . Antihuman antisera 60 0 Ovine 50 
40  
1 1 I 1 1 I /k 
0 100 200 300 400 500 
Calcitonin concentration, pg/ml 
Figure 8-11. Radioimmunoassay for human calcitonin. 
No cross-reactivity of calcitonin of the other 
species tested occurs. 
Calcium-infusion period 
 
0 45 90 135 180 225 270 
Time, min 
( a )  Calcium conce.ntration. 
Calcium-infu sion period 
 
90 180 270 0 
Time, min 
( b )  Calcitonin concentration. 
Figure 8-12. Calcium concen- 
t r a t i o n  and ca l c i ton in  
concentration i n  a pa t i en t  
with medullary thyro id  
carcinoma by calcium in- 
f b i o n  at two r a t e s ,  
6 mg/kg/hr ( and 0 )  and 
12  mg/kg/hr ( o and 0). 
. 
8-21 
" .  
. 
Calcium 
Before After 105 
lo5 
lo2 
Glucagon 
Before After 
EDTA 
efore Afte 
Figure 8-13. Effect of func t iona l  t e s t s  
on t h e  secre t ion  of ca l c i ton in  i n  pa- 
t i e n t s  with medullary thyro id  carc i -  
noma. The l i n e s  connecting symbols 
i nd ica t e  changes f o r  d i f f e r e n t  
pa t i en t s .  
1 .o 
- .8 
n 
E .6 
= .4 ", 
.2 
m 
C 
m 
.- 
Y .- > 
LL 
\ 
I ,  
0 10 20 30 40 " 100 
Absolute/concentration , mg 
Figure 8-14. Standard curves of com- 
p e t i t i v e  binding assay f o r  
vitamin D ( 0 )  and 25-OH 
vitamin D (x). 
3 
3 
9. PEPTIDE HORMONES I N  URINE 
t 
' By Don H. Nelson, M.D." and John E.  Bethune, M.D.  
INTRODUCTION 
The program of studying peptide hormones i n  ur ine  w a s  i n i t i a t e d  as 
p a r t  o f  an ove ra l l  inves t iga t ion  of t h e  e f f e c t s  of space f l i g h t  on bone 
metabolism as r e l a t e d  t o  a p i tu i ta ry-adrena l  s t r e s s  and parathyroid 
hormone (PTH) secre t ion .  
would be ava i l ab le  ( f o r  some time i n  t h e  f u t u r e ) ,  it w a s  proposed t o  
develop s u i t a b l e  methods f o r  assaying PTH and adrenocorticatrophic 
hormone (ACTH) i n  ur ine  as measures of s t r e s s  and parathyroid function. 
Therefore, progress i n  assaying these  two peptides w i l l  be summarized i n  
t h i s  repor t .  
Because it w a s  evident t h a t  only ur ine  samples 
DISCUSSION 
Parathyroid hormone has been studied more extensively than ACTH and 
w i l l  be discussed f irst .  Previous s tud ie s  done i n  our labora tory  have 
suggested t h a t  u r ine  contained a ,parathyroid-like substance t h a t  had 
b io logic  proper t ies  similar t o  t h a t  of beef PTH. Therefore, it seemed 
necessary t o  improve t h e  methods of bioassaying and ex t r ac t ing  t h i s  
material from ur ine  quan t i t a t ive ly ,  s o  t h a t  d i f fe rences  between cont ro l  
and i n f l i g h t  conditions would be meaningful. 
assay i n  m i c e  w a s  developed, using thyroparathyrocautery of 8- t o  10-gram 
mice i d  measurement of whole-blood calcium 5 hours after hormone in jec-  
t i o n .  This procedure has proven t o  be r e l i a b l e .  The r e s u l t s  of a 
t y p i c a l  assay a r e  shown i n  f igu re  9-1, which depic t s  l i n e a r i t y  from 
0.03 t o  2.0 United S ta t e s  Pharmacopeia (U.S.P.) u n i t s  of commercial beef 
PTH. A bioassay procedure w a s  used because it was discovered e a r l y  t h a t  
t h e  mater ia l  with b io log ica l  a c t i v i t y  i n  ur ine  d id  not r e a c t  very w e l l  
immunochemically with beef or human PTH. 
such low immunological a c t i v i t y  t h a t  using t h i s  method as a measurement 
A r e l a t i v e l y  simple bio- 
I n  f a c t ,  t h i s  mater ia l  has 
"Chief of Medicine, La t t e r  Day Sa in ts  Hospital ,  S a l t  Lake Ci ty ,  
'Professor of Medicine, University of Southern Cal i forn ia ,  School of 
Utah 84103. 
Medicine, Los Angeles, Cal i forn ia  90033. 
of the  peptide a c t i v i t y  w a s  impossible, For t h i s  reason, it w a s  neces- 
sa ry  t o  study t h e  i d e n t i t y  of t h e  mater ia l  i n  t h e  ur ine .  
performed through a s e r i e s  of experiments i n  which l a r g e  mounts of t h e  
material i n  ur ine  were co l lec ted  and subjected t o  chromatography and disc- 
g e l  e lec t rophores i s .  
on a Sephadex G 5 0  column i s  at a r a t e  i d e n t i c a l  t o  t h a t  of a commercial 
Dextran preparation with an average molecular weight of 9400. 
se rva t ion  suggested tha t  t h e  molecular weight of t h e  mater ia l  w a s  i n  the 
range expected f o r  PTH. 
pa t te rns  of pure beef PTH labe led  w i t h  rad ioac t ive  iodine and bioassayable 
PTH-like a c t i v i t y  from pa t i en t s  with uremia ( f i g .  9-3) and p a t i e n t s  w i t h  
parathyroid adenoma ( f i g .  9-4) were almost i d e n t i c a l .  
run on Sephadex G-75 i n  a 2.5- x 175-cm column and e lu ted  w i t h  0 . 1  molar 
sodium ace ta t e .  The mater ia l  from seve ra l  pa t i en t s  was then co l lec ted  
and chromatographed on a Bio-Gel P-10 column; t h e  eluant w a s  bioassayed, 
counted f o r  r ad ioac t iv i ty ,  and compared w i t h  the  average running rates 
(as shown i n  t h e  lower portion of f i g .  9-5) w i t h  cytochrome c w i t h  a 
molecular weight of 12  300, with Glucagon w i t h  an average molecular 
weight of 3485, and with t h e  Dextran D-10 with a molecular weight of 
9400. 
t o  t ha t  of beef PTH. The material from t h e  e f f luen t  of t he  Bio-Gel 
column w a s  lyophi l ized  and subjected t o  a disc-gel e lec t rophores i s  
( f i g .  9-6) .  
col lec ted  from p a t i e n t s  w a s  applied t s  g e l  B, and a m i x t u r e  of beef PTH 
and t h e  e f f luen t  w a s  applied t o  g e l  C.  The running rates were similar 
and a s i n g l e  peak w a s  observed i n  each instance.  
pure mater ia l  from p a t i e n t s  w a s  then applied t o  a carboxymethylcellulose 
column and e lu t ed  with an increasing gradient of sodium chloride.  Three 
d i s t i n c t  peaks of pro te in  were observed, two of which had bioassayable 
a c t i v i t y  with s p e c i f i c  a c t i v i t i e s  of 500 and approximately 1500 units/mg 
each. 
This study w a s  
A s  shown i n  f igu re  9-2, t h e  b io log ica l  a c t i v i t y  run 
This ob- 
As shown i n  f igures  9-3 and 9-4, t h e  e lu t ion  
These samples were 
It w a s  concluded tha t  t h e  mobili ty of t h i s  material w a s  s i m i l a r  
Pu r i f i ed  beef F T H  w a s  applied t o  g e l  A ,  t h e  ur inary  PTH 
The chromatographically 
Currently, work i s  i n  progress on co l l ec t ing  material from l a r g e  
amounts of ur ine  i n  an attempt t o  i d e n t i f y  these  peaks f u r t h e r .  The two 
peaks have b io log ica l  a c t i v i t y  sharing a dose-response curve i d e n t i c a l  t o  
PTH bu t  have 1 percent o r  less of the immunological a c t i v i t y  of an 
equivalent amount of beef FTH. Therefore, it would seem t h a t  an a l t e r e d  
PTH i s  being measured i n  the ur ine .  
u r ine  co r re l a t e s  with states i n  which ove rac t iv i ty  o r  underac t iv i ty  of 
t h e  parathyroid glands i s  known t o  e x i s t .  
function i s  being r e l i a b l y  measured. The technique f o r  measuring t h i s  
material, as f i n a l l y  evolved, i s  t o  take a 2 b h o u r  a l iquot  of u r ine ,  add 
minute amounts of radioiodinated beef hormone, concentrate t h e  material 
with s i l i c a ,  e l u t e  t h e  s i l i c a  with ac id  acetone, l yoph i l i ze ,  r econs t i t u t e  
(counting t o  cor rec t  f o r  l o s s e s ) ,  and i n j e c t  t h e  mater ia l  i n t o  assay 
animals. 
urine.  
which a smaller a l iquot  of ur ine  would y i e l d  r e l i a b l e  results. 
The concentration of material i n  
It i s  believed that  parathyroid 
Normal subjec ts  have had l e s s  than 40 units/day of PTH i n  t h e  
Currently, an attempt i s  being made t o  develop a procedure i n  
. 
. 
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It has been known fo r  some t i m e  t h a t  a polypeptide with ACTH ac t iv-  
i t y  i s  found i n  ur ine.  It has been shown t h a t  t h e  material i n  ur ine of 
pa t i en t s  w i t h  Addison's disease and Cushing's syndrome i s  immunologically 
reac t ive ;  therefore ,  it has been possible  t o  develop and use an immuno- 
assay f o r  measuring t h i s  mater ia l .  
l iminary,  a comparison of the  bioassayable and immunoassayable ACTH i n  
ur ine of pa t i en t s  with Cushing's syndrome and i n  Addison's d i sease  has 
been made ( t a b l e  9-11. This comparison suggested t h a t  t h e  quant i ty  of 
immunoassayable mater ia l  may, i n  general ,  be greater  than t h e  bioassay- 
ab le  mater ia l .  The same re la t ionship  can be observed t o  be t r u e  f o r  
blood ACTH as w e l l .  Further work on t h i s  needs t o  be done. 
Although r e s u l t s  t o  da te  are pre- 
CONCLUDING REMARKS 
Di f f i cu l ty  has been experienced i n  measuring immunoassayable ACTH 
i n  ur ine of normal subjec ts ,  because t h e  amount i s  barely detectable  by 
assay i n  untreated ur ine ,  perhaps as a r e s u l t  of salt  concentration 
var ia t ion  i n  ur ine  samples. 
lyophi l iza t ion  have f a i l ed .  
adsorption have not been completely successful ,  because reproducib i l i ty  
and recovery rates have not been uniform. Quite l i k e l y ,  minute quanti- 
t i e s  of rad ioac t ive  ACTH w i l l  have t o  be added t o  the  ur ine t o  make cor- 
rec t ions  f o r  each assay, following adsorption by s i l i c a  p a r t i c l e s .  This 
technique w i l l  be advantageous, because one procedure w i l l  be usable f o r  
both PTH and ACTH extract ion.  
Attempts t o  concentrate t he  material by 
Currently, s tud ies  conducted using s i l i c a  
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Patient 
TABLE 9-1.- URINARY ACTH 
Bioassay, 
mU/day 
14.04 
6.44 
6.244 
3.34 
-- 
-- 
-- 
Immunoassay 
32 500 
28 000 
37 250 
12 750 
24 000 
1 5  350 
26 500 
-- 
7 000 
mU/day 
19.4 
18.06 
24.9 
8.5 
16.0 
10.2 
17.6 
-- 
4.6 
Diagnos is 
Cushing's syndrome 
Cushing's syndrome 
Cushing's syndrome 
Addison's disease 
Cushing's syndrome 
(post adrendect omy 1 
Addison's disease 
Cushing's syndrome 
Cushing's syndrome 
(preadrenalectomy 
Post adrenalec t omy 
. 
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10. PRELIMINARY RESULTS OF ACTH RADIOIMMUNOASSAY 
By Bonnalie 0. Campbell, Ph. D.* 
INTRODUCTION 
It i s  most s ign i f i can t  t h a t  an endocrine meeting has been held within 
t h e  Lunar Receiving Laboratory a t  t he  Manned Spacecrafi Center t o  review 
t h e  NASA-sponsored biomedical work r e l a t i n g  t o  man i n  space and t o  dis-  
cuss t h e  current  programs t h a t  w i l l  extend t h e  knowledge obtained from 
the  Gemini and Apollo f l i g h t s  t o  l a te r  Apollo and Skylab missions. It i s  
encouraging t o  note the  formation of a devoted group of s c i e n t i s t s  who 
have, within only a few years ,  developed research programs of  a highly 
applied nature  t h a t  a r e  d i rec ted  t o  t h e  spec i f i c  problems encountered i n  
normal space f l i g h t  and who continue t o  expand t h i s  s c i e n t i f i c  base dur- 
ing a period of general  public apathy. 
Several years ago, D r .  W. W. Kemmerer, Jr.,  and o thers  a t  t h e  Manned 
Spacecrart Center convened a meeting t o  discuss a proposed protocol f o r  
t he  b io logica l  t e s t i n g  of t h e  lunar samples and possible  f a c i l i t i e s  t h a t  
might be needed f o r  such a program. From t h e  i n i t i a l  meeting, t he re  
evolved a year of intensive work t h a t  culminated i n  a b io logica l  protocol 
fo r  what w a s  then ca l l ed  t h e  Lunar  ‘Sample Receiving Laboratory. The com- 
prehensive protocol ( r e f .  10-1) was submitted t o  NASA by t h e  s t a f f  of t h e  
Baylor College of Medicine; more than 100 consultants from t h e  b io logica l  
sciences a s s i s t e d  i n  t h i s  preliminary work. 
DISCUSSION 
The quarantine b io logica l  t e s t i n g  w a s  t o  be a three-point program. 
The first point  involved t h e  establishment of p re f l igh t  and pos t f l i gh t  
microbial  p r o f i l e s  of  t he  crew and spacecraf t .  
were d i r e c t l y  concerned with the  lunar  samples; t o  w i t ,  methods of cul-  
t u r ing  t h e  samples using conventional microbiological techniques, and 
of exposing se lec ted  p lan ts  and animals t o  the  lunar  mater ia ls  f o r  vary- 
ing periods of  time. 
The other  two poin ts  
*Department of  Biochemistry, Baylor College of Medicine, Houston, 
Texas 77025. 
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These t e s t s  were designed with the  object ive of detect ing any r ep l i -  
cable e x t r a t e r r e s t r i a l  agent t h a t  might cons t i t u t e  an immediate hazard t o  
t h e  ear th ly  biosphere o r ,  i n  t h e  case of t h e  crew, of detect ing any indig- 
enous ea r th  form t h a t  might have undergone a l t e r a t i o n s  and become patholog- 
i c a l  during t h e  course of extended space f l i g h t .  This proposed protocol 
w a s  one of t h e  f irst  ser ious attempts made by an outs ide group of scien- 
t i s t s  t o  draw a t t en t ion  t o  the  f a c t  t h a t  man as a b io logica l  e n t i t y  w a s  an 
in t eg ra l  component of a spec i f i c  mission and should be dea l t  with as such 
and t h a t ,  consequently, man w a s  not uniquely exempt from t h e  c lose  scien- 
t i f i c  sc ru t iny  t o  which the  lunar  samples and spacecraf't a r e  subjected 
a f t e r  r e tu rn  t o  ear th .  
During t h i s  period of study, which w a s  devoted t o  formulating con- 
cepts  of t e s t i n g  and assembling laboratory procedures t o  maintain t h e  
biosphere f r e e  of po ten t i a l ly  harmful pathogens, t h e  recurr ing question 
arose -what i s  being done t o  prepare man i n  h i s  immediate environment 
f o r  prolonged existence outs ide t h i s  pro tec t ive  t e r r e s t r i a l  capsule? 
Admittedly, ca re fu l ly  executed programs and chamber s tud ies  of control led 
l i gh t ing ,  d i e t ,  and work and r e s t  schedules had been conducted as well  
as microbial s tud ies  performed under conditions of  high oxygen pressure.  
But t h e  question remained as t o  whether these s tud ies  provided suf- 
f i c i e n t  data on which spec i f i c  recommendations could be made concerning 
man's i n t e rna l  and immediate external  environment so t h a t  such diverse  
parameters as man's problem-solving a b i l i t y ,  depth-perception, sleep-wake 
cycles ,  and so f o r t h  could be protected and maintained funct ional .  
Another question was what va l id  recommendations could be made t o  a f ford  
protect ion against  s t r e s s  and t o  e s t ab l i sh  optimal l i g h t  and sound regi-  
mens of spec i f i c  i n t e n s i t y ,  durat ion,  and frequency. These and other  
l i k e  questions can be answered thoroughly and recommendations can be 
made only when research programs of a pragmatic nature (such as t h e  sub- 
j e c t  of t h i s  symposium) a r e  given support. 
It i s  l i k e l y  t h a t  a study of human adrenal functions may provide 
some answers t o  the  questions of  t he  e f f ec t s  of space f l i g h t  on human 
physiology. Obviously, t h e  problems encountered i n  manned space f l i g h t  
thus far - erythrocyte-mass changes, bone demineralization, cardiovas- 
cu lar  deconditioning -may share some common denominator i n  which 
pi tui tary-adrenal  function i s  of d i r e c t  or i nd i r ec t  s ignif icance.  No 
doubt e x i s t s  t h a t  t h e  hypothalamic-pituitary-adrenal axis has a c e n t r a l  
i n t eg ra t ive  function i n  homeostasis and i n  conditioning t h e  human body t o  
various environmental s t i m u l i  t h a t  a r e  s t r e s s f u l .  
Recently, it has been suggested t h a t ,  f o r  t h e  ea r ly  de tec t ion  of 
d i sease ,  an examination of t he  adrenal-pi tui tary axis might ind ica te  t h e  
i n i t i a t i o n  of a possible diseased s t a t e  before the  onset of  c l i n i c a l  
symptoms. A n  assay f o r  t he  adrenocorticotrophic hormone (ACTH) would 
. 
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thus  be of  value not only i n  serving as an index fo r  t h e  e a r l y  de tec t ion  
of  d i sease ,  but a l s o  i n  defining t h e  s t r e s sed  s t a t e  i n  mission-oriented 
s tud ie s .  This assay would be of considerable importance i n  r e l a t i o n  t o  
f i n a l  crew s e l e c t i o n  for long-duration missions, because a sce r t a in ing  
t h e  s t r e s s  l e v e l  would prevent t h e  commitment of s t r e s sed  crewmen who 
had not exhibited any signs of  p r e f l i g h t  i l l n e s s .  
Because of  t h e  c e n t r a l  r o l e  of t h e  hypothalamic-pituitary-adrenal 
system i n  t h e  organism's response t o  s t r e s s ,  a developmental program has 
been i n i t i a t e d  t o  assess  adrenal cont ro l  mechanisms i n  human and nonhuman 
primates t o  achieve a b e t t e r  understanding of how l e v e l s  o f  p i t u i t a r y  
hormones a f f e c t  human behavior under various conditions.  
To accomplish these  objec t ives ,  t h e  c l i n i c a l  ana ly t i c  technique 
chosen was t h e  radioimmunoassay f o r  ACTH i n  per iphera l  plasma, using t h e  
fundamental assay of Yalow and Berson ( r e f .  10-2) as modified by 
R. A. Donald ( r e f s .  10-3 and 10-4). This assay was o r i g i n a l l y  developed 
i n  a metabolic study f o r  1311-insulin in jec ted  intravenously i n  man. By 
t he  use of t h i s  bas ic  technique, plasma concentrations of  numerous pep- 
t i d e  hormones i n  t h e  picogram (10 
determined immunochemically. Although bioassays e x i s t  f o r  a number of  
t hese  hormones, some a r e  not s u i t a b l e  f o r  rout ine  c l i n i c a l  ana lys i s .  I n  
addi t ion  t o  being inherently complex and va r i ab le ,  t hese  standard assays 
requi re  l a r g e  quan t i t i e s  of blood. 
problems. 
-12 ) -9 or nanogram (10 ) range can now be 
The radioimmunoassay obviates t hese  
The radioimmunoassay fo r  ACTH, although o f fe r ing  t h e  p o t e n t i a l  o f  
grea t  s e n s i t i v i t y  and s p e c i f i c i t y ,  has not been perfected as a rou t ine  
c l in ica l - labora tory  technique, primarily because a l l  t h r e e  key components 
of t h e  assay are not as ye t  commercially ava i lab le .  These components 
a r e  (1) the highly pu r i f i ed  ACTH e s s e n t i a l  i n  t h e  preparation of  reference 
standards,  ( 2 )  a n t i s e r a  w i t h  high t i t r e  and s p e c i f i c i t y ,  and (3) t h e  
iodine-labeled hormone ac t ing  as a t r a c e r .  
Highly pu r i f i ed  ACTH s u i t a b l e  f o r  standardization or rou t ine  radio- 
iod ina t ion  i s  very d i f f i c u l t  t o  ob ta in ,  
were f i r s t  i s o l a t e d  from t h e  sheep and p ig  i n  t h e  ear ly  1940's 
( r e f s .  10-5 and 10-61, few sources of  pu r i f i ed  hormone a r e  r ead i ly  ava i l -  
i s  c i r cu la t ed  as a g i f t  *om one labora tory  t o  another. The ACTH 
requi red  f o r  general  immunization purposes, however, does not need t o  be 
highly p u r i f i e d  and can be obtained from a commercial suppl ie r .  
Antibodies formed i n  response t o  contaminating peptides do not i n t e r f e r e  
i n  t h e  assay. 
Although ac t ive  ACTH preparations 
* ab le  t o  inves t iga to r s  a t  present.  Much of t h e  highly pu r i f i ed  mater ia l  
I 
.. 
Theore t ica l ly ,  i n  any assay only one species of cor t ico t rophin  should 
be used; t h a t  i s ,  i n  t h e  radioimmunoassay f o r  human ACTH, t h e  standards,  
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labeled hormone, and the  ACTH used fo r  immunization should a l l  be human 
ACTH, e i t h e r  na tura l  o r  synthet ic  ( re f .  10-7). 
on the  consideration of specie  s t r u c t u r a l  differences i n  t h e  amino-acid 
sequence fYom pos i t ions  25 t o  33 as numbered from t h e  N-terminal end of 
t he  polypeptide chain. In  p rac t i ce ,  observing these  conditions i s  very 
d i f f i c u l t  , because human ACTH i s  not r ead i ly  ava i lab le .  
This requirement i s  based 
Both 1251 and l3II are commercially ava i lab le  f o r  use i n  t h e  prep- 
a ra t ion  of the  labeled hormone. The 1311-labeled hormone can be prepared 
I 
with a higher spec i f i c  a c t i v i t y  than 1251, but  it has a ha l f - l i f e  o f  only 
approximately 8 days. 
l i f e  of 56 days, which eliminates t h e  need f o r  more frequent iodinat ions.  
In  con t r a s t ,  1251 has a considerably longer ha l f -  
I The iodinat ion procedure tha t  has been used i n  t h e  Baylor College o f  
Medicine labora tor ies  i s  Landon's modification of Hunter's and Greenwood's 
methods ( r e f s .  10-8 t o  10-10). Chloramine-T i s  used as t h e  oxidizing 
agent t o  f a c i l i t a t e  iodinat ion,  and t h e  reac t ion  i s  terminated by t h e  
addi t ion of  sodium metabisu l f i te .  Despite t he  ease and r ap id i ty  of t he  
iodinat ion,  t h e  procedure sometimes y ie lds  unpredictable r e s u l t s  and an 
occasional inexpl icable  f a i l u r e  i s  t o  be an t ic ipa ted .  Experience has 
shown differences i n  the  responses of batches of chloramine-T and 
isotopes t o  t h e  react ion.  
Production of highly spec i f i c  antibodies t o  ACTH i s  perhaps t h e  
most c r i t i c a l  aspect of t he  radioimmunoassay f o r  t h e  hormone, because 
several  animals must be immunized before  an antiserum of  s u i t a b l e  t i t r e  
i s  developed. The reason severa l  animals must be immunized i s  t h e  
tremendous b io logica l  va r i a t ion  i n  t h e  antigen-antibody response. 
p r iva te  communications suggest t h a t  an independent research laboratory 
i n  Kent, England, may be marketing a su i t ab le  a.ntiserum i n  the  near 
fu ture .  
Recent 
A s  a pa r t  of t h e  current  study, a program of antibody production 
has been undertaken, involving the  immunization o f  r abb i t s ,  guinea p igs ,  
and chickens. I n  the  f i r s t  s e r i e s  of immunizations, Duracton w a s  admin- 
i s t e r e d  subcutaneously a t  a 1:l r a t i o  with Freund's complete adjuvant. 
Duracton contains a porcine ACTH combined w i t h  carboxymethyl ce l lu lose ,  
which serves t o  slow the  re lease  of t he  hormone and a l s o  pro tec ts  t h e  
hormone against  immediate inac t iva t ion .  Subsequent booster i n j ec t ions  
have been coupled w i t h  Freund's incomplete adjuvant. Metyrapone, an 
11 6-hydroxylase inh ib i to r ,  w a s  given intramuscularly,  although t h i s  
precaution t o  inh ib i t  t h e  f i n a l  s t e p  i n  cor t icos te ro id  synthesis  i s  not 
always considered e s s e n t i a l  t o  obtaining s a t i s f a c t o r y  antibody t i t r e s .  
R 
R 
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A typ ica l  t i t r a t i o n  curve f o r  preliminary a n t i s e r a  screening is shown 
i n  f igure  10-1. 
plasma, 1 percent (weight t o  volume) c i t r a t e d  lyophi l ized horse plasma 
(Pentex) , and r epur i f i ed  1251-labeled p-ACTH; t h e  d i lu t ions  , of *om 
1:50 t o  1:5000, were allowed t o  incubate f o r  3 days at 4' C .  The con- 
t r o l s  were r abb i t  6 ,  horse plasma, horse plasma with Middlesex l/5OO, and 
a l l  r abb i t  d i lu t ions  of 1:5000 with Middlesex 1/500 added. The Middlesex 
antiserum, one of known s e n s i t i v i t y  and s p e c i f i c i t y ,  was obtained from 
R. A. Donald, p resent ly  a t  Princess Margaret Hospital ,  Christchurch, 
New Zealand, Fa i r  percent binding was  found a t  f i n a l  antibody d i l u t i o n  
of l:5O f o r  r abb i t  1, which suggests continuatioh of t h e  immunization 
regimen. 
The assay tubes contained s e r i a l  d i l u t i o n s  of  rabbit 
A t y p i c a l  var iab le  response t h a t  can be expected with an antibody- 
t i t r a t i o n  curve i s  shown i n  f igure  10-2. 
l ec t ed  approximately 4 weeks a f t e r  t h e  data  shown i n  f igure  10-1 were 
derived. 
d i lu t ions  of  rabbi t  1 antiserum. However, a uniform decrease i n  binding 
of a l l  d i lu t ions  of rabbi t  2 antiserum w a s  noted. In t e re s t ing ly ,  
r abb i t  2 l a t e r  died a f t e r  receiving a booster in jec t ion .  
The plasma samples were col- 
The percent of bound labeled hormone had increased f o r  a l l  
The increasing antibody production shown by plasma taken from 
rabbi t  1 i s  i l l u s t r a t e d  i n  f igure  10-3. After a s a t i s f a c t o r y  t i t r e  has 
been obtained, t h e  next s t e p  i n  an t i s e ra  screening i s  es tab l i sh ing  
standard curves t o  determine t h e  s e n s i t i v i t y  and s p e c i f i c i t y  of t h e  
antiserum i n  question. 
The an t ibody- t i t ra t ion  curves of t h e  f irst  bleeding of  six chickens 
a r e  shown i n  f igure  10-4. 
t he  same as f o r  t h e  r a b b i t s ,  except t h a t  t he  chickens were in jec ted  i n  
the  comb, r a the r  than subcutaneously. Only th ree  of t h e  four  chickens 
in j ec t ed  show a n  antibody response. 
by plasma obtained from chicken 5 and from t h e  cont ro ls  ( 0  percent bind- 
ing ) .  
but screening f o r  antibody production a t  t h i s  t i m e  would be premature. 
The protocol f o r  i n j ec t ion  w a s  e s s e n t i a l l y  
None of t h e  1251-ap-ACTH w a s  bound 
A program of immunization of guinea pigs  has been i n i t i a t e d ,  
The method of radioimmunoassay used i n  t h i s  program i s  t h e  one 
described by R .  A. Donald ( r e f s .  10-3 and 10-41, which he used while a 
fellow a t  t h e  Baylor College of Medicine. 
hormone a r e  pu r i f i ed  before each use.  The hormone i s  adsorbed on s i l i c i c  
ac id  and t h e  undamaged hormone i s  then eluted with a so lu t ion  of acetone 
and a c e t i c  acid.  The ACTH i s  adsorbed from plasma by s i l i c i c  ac id  using 
a similar method. 
l e v e l s  a r e  below t h e  l e v e l s  of  s e n s i t i v i t y  of t he  method cur ren t ly  used. 
Aliquots of t h e  1251-labeled 
This technique i s  necessary because unextracted plasma 
Several  techniques have been devised t o  separate  t h e  bound antibody 
from t h e  unbound f r ac t ion ,  such as t h e  use of talcum powder (hydrated 
I 10-6 
magnesium s i l i c a t e ) ,  ion-exchange r e s i n s ,  a second antibody, and o ther  
methods. The prefer red  technique, a l s o  used by Donald, involves dextran- 
coated charcoal t o  which t h e  unbound ACTH i s  adsorbed. The t o t a l  incu- 
ba t ion  period i s  f o r  5 days a t  4’ C.  
A t y p i c a l  standard curve of an  ex t rac ted  assay f o r  human plasma using 
the  assay method described i s  shown i n  f igure  10-5. 
labeled hormone bound t o  antibody appears t o  be s l i g h t l y  lower than t h e  
values normally obtained with an ex t rac ted  assay, possibly because of t h e  
age of t h e  ah-ACTH used as t h e  reference standard. By use o f t h e  extrac- 
t i o n  method, values have been obtained f o r  c i r c u l a t i n g  plasma l e v e l s  t h a t  
a r e  comparable t o  those  reported f o r  normal subjec ts  exhib i t ing  a d iu rna l  
va r i a t ion  ranging from 0 t o  80 pg/ml ( r e f .  10-11); higher l e v e l s  f o r  
plasma taken during periods of s t r e s s  have been observed. 
The percent of 
I CONCLUDING REMARKS 
The purpose of using t h e  radioimmunochemical assay for ACTH i n  t h i s  
research program i s  t o  e s t a b l i s h  t h e  capab i l i t y  fo r  rou t ine  ana lys i s  of 
human plasma l e v e l s  of cor t ico t rophin  while performing t h r e e  ground- 
based s tudies .  
1. Circula t ing  plasma l e v e l s  of ACTH w i l l  be measured d i r e c t l y  t o  
e s t a b l i s h  base-line values of normal ACTH sec re t ion  obtained under various 
nonstress s i t u a t i o n s .  I n  es tab l i sh ing  these  base-line values,  parameters 
such as sex, time of day, work-rest cyc les ,  l ight-dark cyc les ,  and s o  
f o r t h  w i l l  be considered. 
n i f icance ,  because sex, l ight-dark cyc les ,  and time of day have been 
reported t o  a f f e c t  ACTH l e v e l s  i n  the ra t  ( r e f .  10-12). 
These parameters may be of considerable s ig-  
2. Normal ACTH values obtained under r e s t f u l  conditions w i l l  be 
analyzed i n  real  time fo r  c i rcadian  va r i a t ion  and co r re l a t ed  with ava i l -  
able c o r t i s o l  values t h a t  would ind ica t e  an underlying c i rcadian  rhythm 
i n  t h e  t o t a l  p i tu i ta ry-adrena l  a x i s .  Retiene and o thers  ( r e f .  10-13) 
have provided evidence fo r  t h e  long-suspected d iu rna l  va r i a t ion  of ACTH 
sec re t ion  i n  t h e  nonstressed human. Adrenal co r t i cos t e ro ids  a r e  known 
t o  exhib i t  rhythms of a d iu rna l  or c i rcadian  nature.  Release o f  these  
s t e r o i d s  from adrenal c o r t i c o l  t i s s u e s  i s  a f f ec t ed  by t h e  c i r c u l a t i n g  
plasma l e v e l s  of ACTH. 
8 3. The l i m i t s  of t h e  radioimmunochemical assay i n  determining t h e  
s t r e s sed  s t a t e  as opposed t o  base-line or nonstress values w i l l  be con- 
s idered ,  as well  as t h e  e f f e c t  of s t r e s s  s i t u a t i o n s  on c i r c u l a t i n g  plasma 
l e v e l s ,  Any poss ib le  d is rupt ion  or suppression of t h e  c i rcadian  rhythm 
induced by s t r e s s  conditions w i l l  be evaluated, as w e l l  as t h e  length  of  
time necessary t o  r e tu rn  t o  t h e  normal r e s t i n g  value and pe r iod ic i ty .  
c 
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Figure 10-1.- Typical ti- 
t r a t i o n  curve f o r  prelim- 
inary an t i s e ra  screening. 
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